Scientific Program

Session (Daily)

**This is tentative, and subject to change at a later time.
(As of August 16, 2019)
Sep 4 (Wed) 08:30-10:20

[PG01] Post Graduate Course by A-PHPBA & the 14th International Single Topic Symposium by KAHBPS

GBR 101-102, 1F
Knack and Tips for Biliary-Pancreatic Surgery: Laparoscopic Surgery 
Chairperson(s)
Yuichi Nagakawa (Japan), Chi-Young Jeong (Korea)
08:30-08:50
Single Incision Cholecystectomy In Seok Choi (Korea)
08:50-09:10
Laparoscopic Spleen-Preserving Distal Pancreatectomy Ying Jui Chao (Taiwan)
09:10-09:30
Laparoscopic RAMPS for Left-Sided Pancreatic Cancer Tae Ho Hong (Korea)
09:30-09:50
Laparoscopic Pancreaticoduodenectomy Palanisamy Senthilnathan (India)
09:50-10:10
Laparoscopic Surgery for Choledochal Cyst Masafumi Nakamura (Japan)
10:10-10:20
Discussion
Sep 4 (Wed) 08:30-12:30

[UV01] Unedited Video

GBR 103-105, 1F
I. How I Do It?: Lap Glissonian Pedicle Isolation and Division 
Chairperson(s)
Taejin Song (Korea), Roberto I. Troisi (Saudi Arabia)
08:30-09:05
[Case 1] What's the Difference and Advantage in My Technique
[Case 1] Video Presentation
Yutaro Kato (Japan)
09:05-09:40
[Case 2] What's the Difference and Advantage in My Technique
[Case 2] Video Presentation
Chung Yip Chan (Singapore)
09:40-09:50
Discussion Kenneth Chok (Hong Kong)
Wifanto Saditya Jeo (Indonesia)
II. How I Do It?: Hilar Dissection and Bile Duct Division in Lap Living Donor Hepatectomy 
Chairperson(s)
Go Wakabayashi (Japan), Kit-Fai Lee (Hong Kong)
09:50-10:25
[Case 1] What's the Difference and Advantage in My Technique
[Case 1] Video Presentation
Gyu-Seong Choi (Korea)
10:25-11:00
[Case 2] What's the Difference and Advantage in My Technique
[Case 2] Video Presentation
Ki-Hun Kim (Korea)
11:00-11:10
Discussion Choon Hyuck David Kwon (Korea)
Daniel Cherqui (France)
III. How I Do It?: Lap Right Posterior Sectionectomy 
Chairperson(s)
Koo Jeong Kang (Korea), Harjit Singh (Malaysia)
11:10-11:45
[Case 1] What's the Difference and Advantage in My Technique
[Case 1] Video Presentation
Osamu Itano (Japan)
11:45-12:20
[Case 2] What's the Difference and Advantage in My Technique
[Case 2] Video Presentation
Yang Seok Koh (Korea)
12:20-12:30
Discussion Yuta Abe (Japan)
Alfred Kow (Singapore)
Sep 4 (Wed) 10:40-12:30

[PG02] Post Graduate Course by A-PHPBA & the 14th International Single Topic Symposium by KAHBPS

GBR 101-102, 1F
Knack and Tips for Biliary-Pancreatic Surgery: Advanced Open Surgery 
Chairperson(s)
Sang Geol Kim (Korea), Yi-Ming Shyr (Taiwan)
10:40-11:00
Extended Cholecystectomy for Various GB Cancers Krishnan Raman (Malaysia)
11:00-11:20
Bile Duct Margin-Free Resection for Bismuth Type III and IV Klatskin Tumor Tomoki Ebata (Japan)
11:20-11:40
Pancreatectomy with Major Vessel Resection & Anastomosis Winston Woon (Singapore)
11:40-12:00
Total Mesopancreas Excision During Pancreaticoduodenectomy Manabu Kawai (Japan)
12:00-12:20
Pancreaticoduodenectomy with Artery First Approach Sa-ard Treepongkaruna (Thailand)
12:20-12:30
Discussion
Sep 4 (Wed) 13:30-15:20

[PG03] Post Graduate Course by A-PHPBA & the 14th International Single Topic Symposium by KAHBPS

GBR 101-102, 1F
Beginner Course 
Chairperson(s)
Ho-Seong Han (Korea), Chung Yip Chan (Singapore)
13:30-13:50
Difficulty Scoring System for Laparoscopic Liver Resection: What's the Limit Go Wakabayashi (Japan)
13:50-14:10
What Preparation Is Needed to Become a Laparoscopic Liver Surgeon Kenneth Chok (Hong Kong)
14:10-14:30
Prevention and Management of Intraoperative Bleeding Alfred Kow (Singapore)
14:30-14:50
Tips for Making Better View: Lesions on the Unfavorable Location Yuta Abe (Japan)
14:50-15:10
How to Use Laparoscopic Ultrasonography Il Young Park (Korea)
15:10-15:20
Discussion
Sep 4 (Wed) 13:30-17:30

[UV02] Unedited Video

GBR 103-105, 1F
Learn the Details and Tips for Various MIS Pancreatoduodenectomy 
Chairperson(s)
Chang Moo Kang (Korea), Chirag Desai (India)
13:30-13:35
[Introduction] Conventional Laparoscopic PD Yuichi Nagakawa (Japan)
13:35-13:40
[Introduction] Pure Robotic PD Shin-E Wang (Taiwan)
13:40-13:45
[Introduction] Laparoscopic and Robotic Hybrid PD Jin-Young Jang (Korea)
13:45-17:30
Video Presentation & Discussion [Speaker]
Yuichi Nagakawa (Japan)
Shin-E Wang (Taiwan)
Jin-Young Jang (Korea)
[Discussant]
Yoo-Seok Yoon (Korea)
Wenhui Lou (China)
Sep 4 (Wed) 15:40-17:15

[PG04] Post Graduate Course by A-PHPBA & the 14th International Single Topic Symposium by KAHBPS

GBR 101-102, 1F
Advanced Course  
Chairperson(s)
Hironori Kaneko (Japan), Guanyu Wang (China)
15:40-16:00
Major Anatomical Laparoscopic Liver Resection Kuo-Hsin Chen (Taiwan)
16:00-16:20
Laparoscopic Hepatectomy for Central Located Tumor Ji Hoon Kim (Korea)
16:20-16:40
Laparoscopic Hepatectomy for Minor Liver Resection Jai Young Cho (Korea)
16:40-17:00
Laparoscopic Donor Hepatectomy Choon Hyuck David Kwon (USA)
17:00-17:15
Discussion
Sep 5 (Thu) 07:40-08:40

[ME01] Meet the Experts

GBR 101-102, 1F
How to Deal with Metastatic Liver Tumors 
07:40-08:00
Liver Resection for Non-CRC/Non-NET Liver Metastases William R. Jarnagin (USA)
08:00-08:20
Management of NET Liver Metastasis Palepu Jagannath (India)
08:20-08:40
Discussion
Sep 5 (Thu) 07:40-08:40

[ME02] Meet the Experts

GBR 103, 1F
Prevention and Management of Complications After Pancreatectomy 
Chairperson(s)
Rajeev Joshi (India), Jinseok Heo (Korea)
07:40-08:00
Pancreatic Fistula Hiroki Yamaue (Japan)
08:00-08:20
Bleeding and Vascular Complications Dong-Sup Yoon (Korea)
08:20-08:40
Discussion
Sep 5 (Thu) 07:40-08:40

[ME03] Meet the Experts

GBR 104-105, 1F
Advanced Management of Biliary and Pancreas Tumors 
Chairperson(s)
Young Hoon Roh (Korea), Goro Honda (Japan)
07:40-08:00
Laparoscopic Management of Gallbladder Cancer Xabier de Aretxabala (Chile)
08:00-08:20
Pancreatic Neuroendocrine Tumours - When to Operate and When to Observe Kevin Conlon (Ireland)
08:20-08:40
Discussion
Sep 5 (Thu) 07:40-08:40

[ME04] Meet the Experts

Room 201, 2F
The Art of Liver Transplantation-How I Do It 
07:40-08:00
Living Donor Hepatectomy Wei-Chen Lee (Taiwan)
08:00-08:20
Recipient Operation in LDLT Jae-Won Joh (Korea)
08:20-08:40
Discussion
Sep 5 (Thu) 07:40-08:40

[ME05] Meet the Experts

Room 202, 2F
Optimal Extent of Resection for Pancreatic Cancer 
Chairperson(s)
Sohei Satoi (Japan), In Seok Choi (Korea)
07:40-08:00
Head Cancer Sun-Whe Kim (Korea)
08:00-08:20
Body & Tail Cancer Satoshi Hirano (Japan)
08:20-08:40
Discussion
Sep 5 (Thu) 07:40-08:50

[ME06] Meet the Experts

Room 203, 2F
Interesting Issues in Liver Surgery 
07:40-08:00
Technical Evolution of ALPPS to Avoid Complications Orlando Jorge Torres (Brazil)
08:00-08:20
Liver Transplantation for Inherited Metabolic Liver Diseases Zhi-jun Zhu (China)
08:20-08:40
Complex Anatomy to Preclude Live Donor Right Hepatectomy Prashant Bhangui (India)
08:40-08:50
Discussion
Sep 5 (Thu) 08:50-09:50

[OC] Opening Ceremony & Presidential Lecture

Auditorium, 3F
Opening Ceremony 
08:50-09:10
Opening Ceremony
Presidential Lecture 
Chairperson(s)
Masakazu Yamamoto (Japan), Martin Smith (South Africa)
09:10-09:30
Progress and Future in Living Donor Liver Transplantation Kyung-Suk Suh (Korea)
09:30-09:50
Surgical Strategies for Gallbladder Carcinoma According to T Stage Dong Wook Choi (Korea)
Sep 5 (Thu) 09:50-10:40

[LL] Living Legend Lecture

Auditorium, 3F
Living Legend Lecture 
Chairperson(s)
Norihiro Kokudo (Japan), Sun-Whe Kim (Korea)
09:50-10:15
Living Donor Liver Transplantation for Seriously-Ill Patients Sung-Gyu Lee (Korea)
10:15-10:40
History and Advancement of Pancreatic Surgery Akimasa Nakao (Japan)
Sep 5 (Thu) 11:00-12:30

[SY01] Symposium

GBR 101-102, 1F
Updates in Innovative Techniques for Liver Surgery 
Chairperson(s)
Jigjidsuren Chinburen (Mongolia), Masaru Miyazaki (Japan)
11:00-11:20
Simulation and 3-D Reconstruction Using Software Program for Liver Surgery Atsushi Sugioka (Japan)
11:20-11:40
Augmented Reality Guided Navigation for Liver Surgery Maki Sugimoto (Japan)
11:40-12:00
ICG Fluorescence Image-Guided Liver Surgery Catherine Teh (Philippines)
12:00-12:20
Robotic Liver Resection Gi Hong Choi (Korea)
12:20-12:30
Discussion
Sep 5 (Thu) 11:00-12:30

[SY02] Symposium

GBR 103, 1F
Evidence of Oncologic Effectiveness of Radical Resection for Pancreatic Cancer 
Chairperson(s)
Dong-Sup Yoon (Korea), Keita Wada (Japan)
11:00-11:20
Total Mesopancreas Excision Yu-Wen Tien (Taiwan)
11:20-11:40
Radical Antegrade Modular Pancreatosplenectomy (RAMPS) Sohei Satoi (Japan)
11:40-12:00
Combined Vascular Resection and Reconstruction During Pancreatectomy Wentao Gao (China)
12:00-12:20
Conversion Surgery for Initially Unresectable Pancreatic Cancer Tsutomu Fujii (Japan)
12:20-12:30
Discussion
Sep 5 (Thu) 11:00-12:30

[SY03] Symposium

GBR 104-105, 1F
Palliative Management of Unresectable Periampullary Tumor 
Chairperson(s)
Seog Ki Min (Korea), Katsuhiko Uesaka (Japan)
11:00-11:20
Surgical vs. Non Surgical Palliation of Advanced Periampullary Tumor : In View of Quality of Life Anil Kumar Agarwal (India)
11:20-11:40
Minimally Invasive Surgery for Palliation of Malignant Biliary Obstruction Tae Ho Hong (Korea)
11:40-12:00
Palliation for Duodenal Obstruction : When & How Ippei Matsumoto (Japan)
12:00-12:20
Palliative Pancreaticoduodenectomy Yi-Ming Shyr (Taiwan)
Sep 5 (Thu) 11:00-12:30

[SY04] Symposium

Room 201, 2F
How to Improve Oncologic Outcomes of Liver Transplantation for HCC 
Chairperson(s)
Hee Jung Wang (Korea), Chao-Long Chen (Taiwan)
11:00-11:20
Radiologic Prediction of Tumor Biology Jeong Min Lee (Korea)
11:20-11:40
Down-Staging Gonzalo Sapisochin (Canada)
11:40-12:00
Optimal Selection Based on Biomarker and Other Noninvasive Measurements Kwan Man (Hong Kong)
12:00-12:20
Tailored Immunosuppression Kwang-Woong Lee (Korea)
12:20-12:30
Discussion
Sep 5 (Thu) 11:00-12:30

[SY05] Symposium

Room 202, 2F
The Current Knowledge and Methods for the Safest Cholecystectomy 
Chairperson(s)
Il Young Park (Korea), Paleswan Joshi Lakhey (Nepal)
11:00-11:20
KSQIP-Laparoscopic Cholecystectomy Hyeon Kook Lee (Korea)
11:20-11:40
The Appropriate Indicators of Surgical Difficulty During Laparoscopic Cholecystectomy (Japan - Korea - Taiwan Survey) Yukio Iwashita (Japan)
11:40-12:00
Intraoperative Technique to Identity the Bile Duct Ting Pong Fung (Hong Kong)
12:00-12:20
Management of Bile Duct Injury During Laparoscopic Cholecystectomy ; All Inclusive of Interventional & Surgical Approaches Boonchoo Sirichindakul (Thailand)
Sep 5 (Thu) 11:00-12:30

[KR] Korean Session

Room 203, 2F
HBP Surgery and the Future Made Easy for Nurses, Residents, and Students
간호사, 전공의, 학생을 위한 쉽게 듣는 간담췌외과와 미래 
Chairperson(s)
Jeong Hee Yoon (Korea), Chang Moo Kang (Korea)
11:00-11:20
Development and Recent Updates in Treatment of Hepatocellular Carcinoma
간암치료의 변천과 최신지견
Jong Man Kim (Korea)
11:20-11:40
Case-Based Learning: Diagnosis and Treatment of Pancreatic Cancer
증례로 보는 췌장암의 진단과 치료
Chi-Young Jeong (Korea)
11:40-12:00
Anatomy and Diseases Seen on Imaging
영상으로 보는 간담췌의 해부학 및 질환
Jeong Hee Yoon (Korea)
12:00-12:20
The Future Operation Room of HBP Surgery
간담췌외과의 미래 수술장
Chang Moo Kang (Korea)
12:20-12:30
Q&A
Sep 5 (Thu) 12:30-13:30

[LS01] Luncheon Symposium

GBR 101-102, 1F
GC Pharma 
Chairperson(s)
Hee Jung Wang (Korea)
12:30-13:30
Cn Lenvervimab Monotherapy Replace Combination Therapy of NA and Plasma-Derived HBIG? Kwang-Woong Lee (Korea)
Sep 5 (Thu) 12:30-13:30

[LS02] Luncheon Symposium

GBR 103, 1F
Stryker 
Chairperson(s)
Kyung-Suk Suh (Korea)
12:30-13:30
Fluorescence Imaging in Liver Surgery: Techniques and Applications in Open and Laparoscopic Anatomic Segmentectomy, Identification of Tumors and Margins and Identification of Intrahepatic and Extrahepatic Biliary Structures Xiaoying Wang (China)
Sep 5 (Thu) 13:30-13:50

[UP01] Update Lecture

GBR 101-102, 1F
Personalize Your Oncologic Practice 
Chairperson(s)
Masaki Ueno (Japan)
13:30-13:50
Precision Medicine in HBP Malignancy Bhawna Sirohi (India)
Sep 5 (Thu) 13:30-13:50

[UP02] Update Lecture

GBR 103, 1F
Changing the Game of Fight Against Pancreatic Cancer 
Chairperson(s)
Kevin Conlon (Ireland)
13:30-13:50
Neoadjuvant vs. Upfront Surgery in Resectable Pancreatic Cancer Michiaki Unno (Japan)
Sep 5 (Thu) 13:30-13:50

[UP03] Update Lecture

GBR 104-105, 1F
Tips for Management of Chronic Pancreatitis 
Chairperson(s)
Guduru Venkat Rao (India)
13:30-13:50
Support for Early Surgery in Chronic Pancreatitis Martin Smith (South Africa)
Sep 5 (Thu) 13:30-13:50

[UP04] Update Lecture

Room 201, 2F
Innovative Surgical Treatment for Pancreatitis 
Chairperson(s)
Shailesh V. Shrikhande (India)
13:30-13:50
Total Pancreatectomy and Islet Auto-Transplantation for Chronic and Acute Recurrent Pancreatitis Varvara Kirchner (USA)
Sep 5 (Thu) 13:30-13:50

[UP05] Update Lecture

Room 202, 2F
Splenic Disease and Treatment 
Chairperson(s)
Wooil Kwon (Korea)
13:30-13:50
Management in Spleen Neoplasm: Is Vaccination Needed Before Surgery? Toar J.M. Lalisang (Indonesia)
Sep 5 (Thu) 13:30-15:00

[JS01] A-PHPBA & A-PLHPDEC Joint Symposium

Room 203, 2F
How to Develop and Promote Laparoscopic Liver Resection in the Asia-Pacific Region 
Chairperson(s)
Xiao-ping Chen (China), Marcos Perini (Australia)
13:30-13:45
How to Establish Guideline of Patient Selection for Laparoscopic Hepatectomy Wifanto Saditya Jeo (Indonesia)
13:45-14:00
Standardization of Techniques for Laparoscopic Hepatectomy Hiroyuki Nitta (Japan)
14:00-14:15
What Are the Latest Developments in Laparoscopic Hepatectomy? Wanguang Zhang (China)
14:15-14:30
Laparoscopy Will Replace Open?: Comparison of Technical and Oncological Outcomes Between Them Ho-Seong Han (Korea)
14:30-15:00
Discussion Mikhail Efanov (Russia)
Kuohsin Chen (Taiwan)
Palanisamy Senthilnathan (India)
Munkhbat Radnaabazar (Mongolia)
Xiu-Jun Cai (China)
Xiaoying Wang (China)
Goro Honda (Japan)
Jong Man Kim (Korea)
Sep 5 (Thu) 13:50-15:00

[BV01] Best Video

GBR 101-102, 1F
Chairperson(s)
Taejin Song (Korea), David Cavallucci (Australia)
13:50-14:00
Totally Laparoscopic ALPPS Jong Man Kim (Korea)
14:00-14:10
Laparoscopic Liver Resection in Segment 7: Hepatic Vein First Approach with Special Reference to Sufficient Resection Margin Boram Lee (Korea)
14:10-14:20
Extended Right Hepatectomy with Anterior Approach for Infant Hepatoblastoma Xiangcheng Li (China)
14:20-14:30
Full Laparoscopic Anatomical Segment 8 Resection for Hepatocellular Carcinoma Using the Glissonian Approach with Indocyanine Green Dye Fluorescence Giammauro Berardi (Japan)
14:30-14:40
Combined Resection of the Hepatic Venous Confluence Following Preoperative Embolization of the Right Hepatic Vein for Liver Tumor Invading Three Hepatic Veins Takashi Mizuno (Japan)
14:40-14:50
Anatomical Segment 1, 4 Resection with Hanging Tape and Selective Hepatic Pedicle Control Khai Ninh Viet (Vietnam)
14:50:15:00
Laparoscopic Segmentectomy 1 for Adenoma Daniel Cherqui (France)
Sep 5 (Thu) 13:50-15:00

[BV02] Best Video

GBR 103, 1F
Chairperson(s)
Sang Mok Lee (Korea), Yasuyuki Suzuki (Japan)
13:50-14:00
Robotic Pylorus Preserving Pancreatico-Duodenectomy Vikram Chaudhari (India)
14:00-14:10
Autogenic Splenic Implantation in Distal Pancreatectomy with Splenectomy for Benign Lesions of the Distal Pancreas (RESTORE) Alma Moekotte (United Kingdom)
14:10-14:20
Ultrasonic Dissection for Pancreatic Stump Management in Laparoscopic Radical Antegrade Pancreatosplenectomy Paramin Muangkaew (Thailand)
14:20-14:30
Pancreatojejunostomy Using Modified Blumgart Technique Adapted for Minimally Invasive Pancreatoduodenectomy Kalayarasan Raja (India)
14:30-14:40
Laparoscopic Transabdominal Left Adrenalectomy Laparoscopic Spleen-Preserving Subtotal Pancreatectomy with Indocyanine Green (ICG) Application Katherine Panganiban (Philippines)
14:40-14:50
Total Laparoscopic Pylorus-Preserving Pancreatico-Duodenectomy Saiesh Reddy Voppuru (India)
14:50:15:00
Laparoscopic Central Pancreatectomy Under Clampage of the Portomesenteric Vein and Resection of Splenic Vessels for Large Solid and Cystic Pseudopapillary Tumor Safi Dokmak (France)
Sep 5 (Thu) 13:50-15:00

[BV03] Best Video

GBR 104-105, 1F
Chairperson(s)
Yoo Shin Choi (Korea), Chang Moo Kang (Korea)
13:50-14:00
Laparoscopic Retrieval of Impacted and Broken Dormia Basket During ERCP Stone Clearance Vaibhav Kumar Varshney (India)
14:00-14:10
Right Trisectionectomy and Bile Duct Resection in a Case of Aberrant A2+3 Running the Right Side of Left Portal Vein Yang Won Nah (Korea)
14:10-14:20
Robotic Surgery for Gallbladder Cancer: Operative Technique and Early Outcomes Amit Gupta (India)
14:20-14:30
Laparoscopic Repair of Postcholecystectomy Bile Duct Injury with Partial Segment IV Resection for Exposition Safi Dokmak (France)
14:30-14:40
Early Experience of Robotic Extended Cholecystectomy in Gallbladder Cancer Yoonhyeong Byun (Korea)
14:40-14:50
Right Hepatectomy with Portal Vein Reconstruction for Hilar Cholangiocarcinoma Xiangcheng Li (China)
14:50:15:00
Laparoscopic Common Bile Duct Exploration and Choledochoduodenostomy for Totally Gastrectomized Patient with Diversed Gastrointestinal Tract Heontak Ha (Korea)
Sep 5 (Thu) 13:50-15:00

[BV04] Best Video

Room 201, 2F
Chairperson(s)
Youngkyoung You (Korea), Geoff McCaughan (Australia)
13:50-14:00
Pure Laparoscopic Living Donor Right Hepatectomy Daniel Cherqui (France)
14:00-14:10
Pure Laparoscopic Donor Right Hepatectomy in Donor with Severe Portal Vein Anomaly Ja Ryung Han (Korea)
14:10-14:20
Right Anterior Section Graft for Living-Donor Liver Transplantation Jonathan Navarro (Philippines)
14:20-14:30
Left Trisection Plus Caudate Lobe Graft in Living Donor Liver Transplantation Taizo Hibi (Japan)
14:30-14:40
Living Donor Liver Transplantation Using Left Trisection Graft with Caudate Lobe Dong-Hwan Jung (Korea)
14:40-14:50
Pure Laparoscopic Living Donor Left Lateral Sectionectomy with a Variant Anatomy for a Pediatric Liver Transplantation Abdulwahab A. Alshahrani (Saudi Arabia)
14:50:15:00
No Touch Left Approach for Right Lobe Advanced HCC to Decrease HCC Recurrence Gil-Chun Park (Korea)
Sep 5 (Thu) 13:50-15:00

[BV05] Best Video

Room 202, 2F
Chairperson(s)
DongHee Ryu (Korea), Keiji Sano (Japan)
13:50-14:00
Third Hepatectomy for Recurrent Colorectal Liver Metastasis and Double Reconstruction of the Hepatic Vein and Vena Cava with Peritoneal Patches Under Total Vascular Occlusion Safi Dokmak (France)
14:00-14:10
Laparoscopic Anatomical S8 Segmentectomy with ICG Fluorescence Staining by Laparoscopic Ultrasound Guided Portal Branch Puncture Approach Xiaoying Wang (China)
14:10-14:20
Laparoscopic Right Hepatectomy and Distal MHV Resection After Portal Vein Embolization for Intraductal Papillary Neoplasm of Bile Duct Wipusit Taesombat (Thailand)
14:20-14:30
Central Hepatectomy with Vascular Reconstruction Saurabh Singhal (India)
14:30-14:40
Surgical Tips of Pure 3D Laparoscopic Donor Right Hemihepatectomy Obtained from Initial Experience and Complications Jeong-Moo Lee (Korea)
14:40-14:50
The Initiation of Laparoscopic Donor Right Hepatectomy in Singapore Ning Qi Pang (Singapore)
14:50:15:00
Robotic Right Hemihepatectomy with Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Sung Hoon Choi (Korea)
Sep 5 (Thu) 15:20-16:20

[OR01] Oral

GBR 101-102, 1F
Chairperson(s)
Young Seok Han (Korea), Adianto Nugroho (Indonesia)
15:20-15:30
Advantages of Controlled Low Central Venous Pressure in Laparoscopic Hepatectomy for Hepatocellular Carcinoma - A Randomized Clinical Trial Yangxun Pan (China)
15:30-15:40
Laparoscopic Hepatectomy (With or Without Robotic Assistance) Versus Open Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis of 336 Patients Charing Chong (Hong Kong)
15:40-15:50
Surgical Resection Should Be Considered in Resectable Solitary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis of Patients with Child A Jong Man Kim (Korea)
15:50-16:00
Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients Jingcheng Hao (China)
16:00-16:10
Total Tumor Volume Based Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Jin-Chiao Lee (Taiwan)
16:10-16:20
FBXW7 Mutation Is Associated with Decreased Survival Following Hepatectomy for Metastatic Colorectal Cancer Timothy Newhook (United States)
Sep 5 (Thu) 15:20-16:20

[OR02] Oral

GBR 103, 1F
Chairperson(s)
Ganesh Nagarajan (India), Kee Hwan Kim (Korea)
15:20-15:30
Effects of High-Dose Pancreatic Enzyme Replacement Therapy on Body Weight, Nutritional Status, and Quality of Life After Pancreaticoduodenectomy Hongbeom Kim (Korea)
15:30-15:40
The Benefit of Adjuvant Chemotherapy in the Subtypes of Ampullary Adenocarcinoma: International Propensity Score Matched Study Alma Moekotte (United Kingdom)
15:40-15:50
How To Determine the Surgery in Patients with Intraductal Papillary Mucinous Neoplasm of Pancreas: Validation of the Nomogram Predicting the Individual Risk of Malignancy and ACS NSQIP Surgical Risk Calculator Seung Jae Lee (Korea)
15:50-16:00
Decreased Serum CA19-9 Levels After Neoadjuvant Therapy Predict a Low Incidence of Hepatic Recurrence After Surgery and a Better Prognosis for Patients with Pancreatic Adenocarcinoma: A Multicenter Case-Control Study of 240 Patients Shuichi Aoki (Japan)
16:00-16:10
Clinical Validation of the 2017 International Consensus Guidelines on Intraductal Papillary Mucinous Neoplasm of the Pancreas Jae Seung Kang (Korea)
16:10-16:20
Biomarker Panel Predicts Survival After Resection in Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Cohort Study Christopher Nahm (Australia)
Sep 5 (Thu) 15:20-16:20

[OR03] Oral

GBR 104-105, 1F
Chairperson(s)
Sungho Jo (Korea), Kenichi Hakamada (Japan)
15:20-15:30
Risk Factors and the Time of Occurrence on the Development of CBD Stones After LC Kwang Woo Choi (Korea)
15:30-15:40
Deregulated Canonical-WNT Signalling Modulated Downstream Events as Inflictors of Gallbladder Anomalies and Carcinoma in North-East Indian Population Nidhi Singh (India)
15:40-15:50
Evaluation of Postoperative Adjuvant Treatment for Ampulla of Vater Carcinoma: Multicenter, Retrospective Study Hyung Sun Kim (Korea)
15:50-16:00
Molecular Characteristics Associated with 18F-FDG Uptake in Intrahepatic Cholangiocarcinoma Keun Soo Ahn (Korea)
16:00-16:10
Surgical Outcomes of Left Trisectionectomy Combined with Vascular Reconstruction for Perihilar Cholangiocarcinoma Ryusei Matsuyama (Japan)
16:10-16:20
PRALPPS in Patients with Perihilar Cholangiocarcinoma: Analysis of Short-Term Outcomes Mikhail Efanov (Russia)
Sep 5 (Thu) 15:20-16:20

[OR04] Oral

Room 201, 2F
Chairperson(s)
Minoru Tanabe (Japan), Kenneth Chok (Hong Kong)
15:20-15:30
Pure Laparoscopic Donor Hepatectomy: Korean Multicenter Experience Suk Kyun Hong (Korea)
15:30-15:40
Variables Impacting on the Outcomes After Liver Transplantation for Hepatocellular Cancer Within UCSF Criteria Eunice Lee (Australia)
15:40-15:50
Liver Transplantation – The Best and Last Chance of Cure for Hepatocellular Carcinoma with Portal Vein Invasion Ka Wing MA (Hong Kong)
15:50-16:00
Silent Allograft Fibrosis in 10-Year Post-Transplantation Histology of Pediatric Liver Transplantation: Is It Really Silent? Jinsoo Rhu (Korea)
16:00-16:10
No-Touch En-Bloc Total Hepatectomy Technique in Living-Donor Liver Transplantation for Hepatocellular Carcinoma Youngin Yoon (Korea)
16:10-16:20
Older Donor Age Is the Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts Mahmoud Macshut (Japan)
Sep 5 (Thu) 15:20-16:20

[OR05] Oral

Room 202, 2F
Chairperson(s)
Hyung Il Seo (Korea), Krishnan Raman (Malaysia)
15:20-15:30
Exploratory Study for the Application of Photodynamic Diagnosis to Biliary Pancreatic Surgery Takehiro Noji (Japan)
15:30-15:40
Gold Nanoparticles Inhibit Colon Cancer Liver Metastasis Through Regulation of the TGF-β Pathway Binhao Zhang (China)
15:40-15:50
Preoperative Portal Vein Ligation Meets Unmet Liver Regeneration Following Hepato-Pancreatectomy Through Augmented Autophagy- Trash to Cash Chun-Yi Tsai (Taiwan)
15:50-16:00
A Study of Preoperative Difficulty Factors for Pancreatoduodenectomy Kenichi Mizunuma (Japan)
16:00-16:10
Discordance Between Pathological Grade and Clinical Behaviour of Gastroenteropancreatic Neuroendocrine Neoplasms: A Premise for Dual Nuclear Imaging Based Treatment Approach Gunjan Desai (India)
16:10-16:20
Hepatocellular Carcinoma Research Platform from Patient-Derived Xenograft to Organoid Toward Biobanking for Precision Medicine Shin Hwang (Korea)
Sep 5 (Thu) 15:20-16:40

[JS02] A-PHPBA & KSPEN Joint Symposium

Room 203, 2F
Nutritional Support in Older Patients 
Chairperson(s)
Sang-Jae Park (Korea), Kyung Sik Kim (Korea)
15:20-15:25
Opening Remarks Ho-Seong Han (Korea)
15:25-15:40
Age Related Sarcopenia : Nutritional Screening, Assessment and Diagnosis Seung-Wan Ryu (Korea)
15:40-15:55
Dietary Advice and Oral Nutritional Supplement in Older Patients Eunmee Kim (Korea)
15:55-16:10
Nutritional Support After Major Hepatectomy in Older Patients Jin Hong Lim (Korea)
16:10-16:25
Nutritional Support After Pancreatoduodenectomy in Older Patients Thakur Deen Yadav (India)
16:25-16:40
Discussion
Sep 5 (Thu) 16:20-16:40

[UP06] Update Lecture

GBR 101-102, 1F
The Future Is Coming 
Chairperson(s)
Hyo-Keun Lim (Korea)
16:20-16:40
Artificial Intelligence (AI) in Liver Imaging Sungwon Kim (Korea)
Sep 5 (Thu) 16:20-16:40

[UP07] Update Lecture

GBR 103, 1F
Update on IPMN 
Chairperson(s)
Masao Tanaka (Japan)
16:20-16:35
Surveillance Strategy for IPMN: Evidence-Based Approach Jin-Young Jang (Korea)
16:35-16:40
Discussion
Sep 5 (Thu) 16:20-16:40

[UP08] Update Lecture

GBR 104-105, 1F
How to Balance Efficacy and Toxicity of Chemotherapy in Bile Duct Cancer 
Chairperson(s)
Kuk Hwan Kwon (Korea ), Masayuki Ohtsuka (Japan)
16:20-16:40
Current Evidence on Postoperative Adjuvant Treatment in Biliary Tract Cancer Joon Seong Park (Korea)
Sep 5 (Thu) 16:20-16:40

[UP09] Update Lecture

Room 201, 2F
Bioengineering Techniques and Liver Transplantation 
Chairperson(s)
Suk-Koo Lee (Korea)
16:20-16:40
Bioartificial Liver: From Bench to Clinic David Mulligan (USA)
Sep 5 (Thu) 16:20-16:40

[UP10] Update Lecture

Room 202, 2F
Update on IPNB 
Chairperson(s)
Seung Eun Lee (Korea)
16:20-16:40
Current Concepts and Clinical Implication of Intraductal Papillary Neoplasm of the Bile Duct (IPNB) Keiichi Kubota (Japan)
Sep 5 (Thu) 16:40-17:50

[SY06] Symposium

GBR 101-102, 1F
Intriguing and Challenging Situations for Treatment of Colorectal Liver Metastasis 
Chairperson(s)
Hiroshi Shimada (Japan), Jin Sub Choi (Korea)
16:40-17:00
How to Deal with Vanishing Lesions After Chemotherapy Christopher Christophi (Australia)
17:00-17:20
Aggressive Surgical Treatments for Colorectal Liver Metastasis Itaru Endo (Japan)
17:20-17:40
RFA for Colorectal Liver Metastasis Hyunchul Rhim (Korea)
17:40-17:50
Discussion
Sep 5 (Thu) 16:40-17:50

[SY07] Symposium

GBR 103, 1F
Clinical Practice for Borderline/Locally Advanced Resectable Pancreatic Cancer 
Chairperson(s)
Soon-Chan Hong (Korea), Tsutomu Fujii (Japan)
16:40-17:00
Ongoing Trials or Current Protocols of Neoadjuvant Thearapy: How Similar and How Different? Yan-Shen Shan (Taiwan)
17:00-17:20
Radiological and Functional Evaluation of Response After Neoadjuvant Therapy Masayuki Sho (Japan)
17:20-17:40
Surgeon's Decision Making Process After Neoadjuvant Therapy Hiroki Yamaue (Japan)
17:40-17:50
Discussion
Sep 5 (Thu) 16:40-17:50

[SY08] Symposium

GBR 104-105, 1F
Differential Diagnosis and Treatment of Biliary Strictures 
Chairperson(s)
Kyung Sik Kim (Korea), Ryota Higuchi (Japan)
16:40-17:00
How Can We Reduce Biliary Stricture? Sadiq S Sikora (India)
17:00-17:20
Surgical Treatment of Biliary Stricture Adianto Nugroho (Indonesia)
17:20-17:40
Endoscopic Management of Biliary Stricture Sung Ill Jang (Korea)
Sep 5 (Thu) 16:40-17:50

[SY09] Symposium

Room 201, 2F
What's New in Liver Transplantation for Non-HCC Malignancies? 
Chairperson(s)
Soon-Il Kim (Korea)
16:40-17:00
LT for NET Jan Lerut (Belgium)
17:00-17:20
LT for Colorectal Liver Metastasis Oscar Imventarza (Argentina)
17:20-17:40
LT for Hilar Cholangiocarcinoma Timucin Taner (USA)
17:40-17:50
Discussion
Sep 5 (Thu) 16:40-17:50

[DE01] Debate Session

Room 202, 2F
The Need for Laparoscopic Cholecystectomy in CBD Stone Patients Without GB Stone 
Chairperson(s)
Il Young Park (Korea), Thakur Deen Yadav (India)
16:40-17:00
Surgery Ramesh Singh Bhandari (Nepal)
17:00-17:20
Observation Kwangbum Cho (Korea)
17:20-17:40
Discussion
Sep 5 (Thu) 16:40-17:00

[UP11] Update Lecture

Room 203, 2F
Neoadjuvant Treatment of Pancreatic Cancer 
Chairperson(s)
Hiroki Yamaue (Japan)
16:40-17:00
Role of Neoadjuvant Therapy in Treatment of Pancreatic Cancer Dejan Radenkovic (Serbia)
Sep 5 (Thu) 17:00-17:20

[UP12] Update Lecture

Room 203, 2F
What's New in Pediatric LT 
Chairperson(s)
Suk-Koo Lee (Korea)
17:00-17:20
Current Status of Pediatric Liver Transplantation in China Qiang Xia (China)
Sep 6 (Fri) 07:40-08:40

[ME07] Meet the Experts

GBR 101-102, 1F
Liver Surgery - That's Complicated 
07:40-08:00
How to Assess the Operation Risk in Hepatectomy Masakazu Yamamoto (Japan)
08:00-08:20
Techniques for Controlling Bleeding During Hepatectomy Xiao-ping Chen (China)
08:20-08:40
Discussion
Sep 6 (Fri) 07:40-08:40

[ME08] Meet the Experts

GBR 103, 1F
Which Is an Ideal Modality for Minimally Invasive Surgery?: Robotic vs. Laparoscopic Pancreatectomy 
Chairperson(s)
Hideyuki Yoshitomi (Japan), Myunghee Yoon (Korea)
07:40-08:00
Laparoscopic Surgery Palanivelu Chinnusamy (India)
08:00-08:20
Robotic Surgery Chung Ngai Tang (Hong Kong)
08:20-08:40
Discussion
Sep 6 (Fri) 07:40-08:40

[ME09] Meet the Experts

GBR 104-105, 1F
Biliary Surgery: A to Z 
Chairperson(s)
Kee-Taek Jang (Korea), Yang Won Nah (Korea)
07:40-08:00
Biliary Pathologic Findings that Surgeons Must Know Volkan Adsay (Turkey)
08:00-08:20
Optimal Preparation for Major Hepatobiliary Resection Masato Nagino (Japan)
08:20-08:40
Discussion
Sep 6 (Fri) 07:40-08:40

[ME10] Meet the Experts

Room 201, 2F
Technical Pearls and Pitfalls in Liver Transplantation 
07:40-08:00
Graft Selection and Modification for Pediatric LDLT Mureo Kasahara (Japan)
08:00-08:20
Special Technical Considerations in Recipient Operation for Children Nam-Joon Yi (Korea)
08:20-08:40
Discussion
Sep 6 (Fri) 07:40-08:40

[ME11] Meet the Experts

Room 202, 2F
Challenges and Novel Approaches in Difficult HBP Surgery 
Chairperson(s)
Bong-Wan Kim (Korea), Ting Pong Fung (Hong Kong)
07:40-08:00
Pediatric Liver Transplantation Oscar Imventarza (Argentina)
08:00-08:20
Venous Reconstruction with the Parietal Peritoneum: How I Do It? Safi Dokmak (France)
08:20-08:40
Discussion
Sep 6 (Fri) 07:40-08:40

[ME12] Meet the Experts

Room 203, 2F
Enhance Your Surgical Skills by Learning Innovative Techniques 
Chairperson(s)
Dejan Radenkovic (Serbia), Saxon Connor (New Zealand)
07:40-08:00
Pancreas Preserving Duodenectomy for Duodenal Neoplasm Horacio J. Asbun (USA)
08:00-08:20
Mesopancreas Excision Using Intestinal Derotation Procedure Masanori Sugiyama (Japan)
08:20-08:40
Discussion
Sep 6 (Fri) 08:40-10:10

[SY10] Symposium

GBR 101-102, 1F
Evidence-Based Minimal Invasive Hepatectomy 
Chairperson(s)
Prasad Wagle (India), Sung Su Yoon (Korea)
08:40-09:00
Oncologic Outcomes of Laparoscopic Liver Resection for HCC Nicholas O'Rourke (Australia)
09:00-09:20
Safety and Reproducibility of Laparoscopic Donor Hepatectomy Over Feasibility Ki-Hun Kim (Korea)
09:20-09:40
Benefits of Robotic Liver Resection Compared to Laparoscopic Surgery Chung Ngai Tang (Hong Kong)
09:40-10:00
Laparoscopic Liver Resection for Hepatic Metastasis Including ALPPS Xiaoying Wang (China)
10:00-10:10
Discussion
Sep 6 (Fri) 08:40-10:10

[SY11] Symposium

GBR 103, 1F
Updates in Pancreatic Neuroendocrine Tumor 
Chairperson(s)
Manabu Kawai (Japan), Arthur Richardson (Australia)
08:40-09:00
Global Epidemiology of PNET Vladimir Trifanov (Russia)
09:00-09:20
Optimal Surgical Treatment Yoo-Seok Yoon (Korea)
09:20-09:40
Management of Metastatic PNET Harjit Singh (Malaysia)
09:40-10:00
New Biomarkers and Emerging Treatment for PNET Wenhui Lou (China)
10:00-10:10
Discussion
Sep 6 (Fri) 08:40-10:10

[SY12] Symposium

GBR 104-105, 1F
Panel Discussion : Controversial Issues in the Published Guideline of GB Cancer 
Chairperson(s)
Anil Kumar Agarwal (India), Ta-Sen Yeh (Taiwan)
08:40-08:55
What Kind of Treatment Will You Do If You Accidentally Find T1b Gallbladder Cancer? Masayuki Ohtsuka (Japan)
08:55-09:10
The Two Sides of Cholecystectomy for Gallbladder Cancer : Open and Laparoscopic Shridhar Ganpathi Iyer (Singapore)
09:10-09:25
Is Tailored Radical Cholecystectomy Possible According to the New T2 Definition Guanyu Wang (China)
09:25-09:45
Case Discussion Woohyung Lee (Korea)
09:45-10:05
Case Discussion Kazuto Shibuya (Japan)
Sep 6 (Fri) 08:40-10:10

[SY13] Symposium

Room 201, 2F
Living Donor: From Ethics to Outcome 
Chairperson(s)
Dong Goo Kim (Korea), Norihiro Kokudo (Japan)
08:40-09:00
Ethical and Legal Issues in Asian-Pacific Region Chung-Mau Lo (Hong Kong)
09:00-09:20
Evaluation and Selection Refaat Kamel (Egypt)
09:20-09:40
Technical Points for Safe Donor Hepatectomy Chao-Long Chen (Taiwan)
09:40-10:00
Long Term Outcome of Living Donor Including Quality of Life Kiyoshi Hasegawa (Japan)
10:00-10:10
Discussion
Sep 6 (Fri) 08:40-10:10

[SY14] Symposium

Room 202, 2F
International Panel Discussion: Training and Educating HPB Surgeons to Meet the International Standards 
Chairperson(s)
Kevin Conlon (Ireland), Christopher Christophi (Australia)
08:40-09:00
The Need for Common Standards for HPB Training in Asia and Pacific Region Javier Lendoire (Argentina)
09:00-09:20
Introduction of Standards for HPB Training Defined by the Education and Training Committee of the IHPBA Kevin Conlon (Ireland)
09:20-10:10
[International Panel Discussion]
Q1. How Can You Become an HPB Surgeon in Your Country?
Q2. Is There a Practical Need for Certified HPB Specialist?
Q3. What Are the Minimal Requirements to Certify a Qualified HPB Surgeon?
Q4. Can an Exchange Training Program Be an Effective Way to Implement Common Standards?
Takao Ohtsuka (Japan)
Christopher Christophi (Australia)
Avinash Supe (India)
Kyung Sik Kim (Korea)
Yinmo Yang (China)
Sep 6 (Fri) 10:30-11:30

[MO01] Mini Oral

GBR 101-102, 1F
Chairperson(s)
Zhi-Yong Huang (China), Michael Fink (Australia)
10:30-10:35
The Clinical Impact of the Treatment Modality of Recurrent Intrahepatic Single and Small Sized Hepatocellular Carcinoma After Primary Liver Resection Hyo-Sin Kim (Korea)
10:35-10:40
Survival Advantage of Laparoscopic Versus Open Resection for Colorectal Liver Metastases: A Patient-Level Meta-Analysis Including 2,539 Participants from 10 Propensity-Score-Matched Studies Nicholas Syn (Singapore)
10:40-10:45
Development and Internal Validation of A Nomogram with Excellent Discrimination and Calibration Statistics for Predicting Long-Term Survival After Hepatectomy for Colorectal Liver Metastases Nicholas Syn (Singapore)
10:45-10:50
A Conceptually-Derived, Normally-Distributed Overall Liver Dysfunction Index (OLDI) Predicts Short- and Long-Term Outcomes After Hepatectomy for Hepatocellular Carcinoma: Single-Institution Validation in 844 HCC Patients Nicholas Syn (Singapore)
10:50-10:55
Anatomical Parenchymal Sparing Liver Resections Using the Glissonian Approach and Indocyanine Green Dye Negative Staining Giammauro Berardi (Japan)
10:55-11:00
Preoperative Neutrophil to Lymphocyte Ratio as a Predictor of Outcome in Patients Undergoing Resection of Colorectal Liver Metastases– A Retrospective Multi-Center Study Yael Berger (Israel)
11:00-11:05
Development of a Novel Navigation System for Liver Resection Yukio Oshiro (Japan)
11:05-11:10
Steroid Administration and Ischemia-Reperfusion Injury in Laparoscopic Liver Resection: A Randomized Controlled Trial Yasushi Hasegawa (Japan)
11:10-11:15
Utility of TACE and RFA for Unresectable Recurrent HCC: Inverse Probability of Treatment-Weighted Subgroup Analyses of Overall Survival Sarah Tham (Singapore)
11:15-11:20
RhoC/ ROCK2 Promotes Vasculogenic Mimicry Formation Primarily Through ERK/MMPs in Hepatocellular Carcinoma Ji-Gang Zhang (China)
Sep 6 (Fri) 10:30-11:30

[MO02] Mini Oral

GBR 103, 1F
Chairperson(s)
Shigeru Marubashi (Japan), Yonghoon Kim (Korea)
10:30-10:35
Chyle Leakage After Robotic and Open Pancreaticoduodenectomy Bor-Uei Shyr (Taiwan)
10:35-10:40
Surgical Outcomes of First 50 Cases of Robotic Pancreaticoduodenectomy: 1st Report in Korea Jae Hoon Lee (Korea)
10:40-10:45
Exosomal miRNA-106b from Cancer-Associated Fibroblast Promotes Gemcitabine Resistance in Pancreatic Cancer Yuan Fang (China)
10:45-10:50
Chemoradiotherapy Is Associated with Improved Survival for Resected Pancreatic Adenosquamous Carcinoma Yuan Fang (China)
10:50-10:55
Development and External Validation of a Nomogram with Inflammatory Markers for Predicting Invasiveness of IPMN So Jeong Yoon (Korea)
10:55-11:00
Robotic-Assisted Pancreaticoduodenectomy with Vascular Resection: Our Initial Experience Marco Vito Marino (Italy)
11:00-11:05
The Vulnerable Point of Modified Blumgart Pancreaticojejunostomy Regarding Pancreatic Fistula Learned from 50 Consecutive Pancreaticoduodenectomy Kwangyeol Paik (Korea)
11:05-11:10
Laparoscopic Pancreaticoduodenectomy with Major Venous Resection and Reconstruction Bing Peng (China)
11:10-11:15
Analysis of Symptomatic Marginal Ulcers in Patients Who Underwent Whipple’s Operation for Peri-Ampullary Tumors Yejong Park (Korea)
11:15-11:20
Preoperative Lymphocyte-to-Monocyte Ratio Is a Superior Systemic Inflammation Marker to Predict Relapses in Patients with Pancreatic Neuroendocrine Neoplasms Following Curative Resections Wentao Zhou (China)
Sep 6 (Fri) 10:30-11:30

[MO03] Mini Oral

GBR 104-105, 1F
Chairperson(s)
Sang Bum Kim (Korea), Ser Yee Lee (Singapore)
10:30-10:35
Modified Staging Classification of Gallbladder Carcinoma on the Basis of the 8th Edition of American Joint Commission on Cancer (AJCC) Staging System Jie Wang (China)
10:35-10:40
The Feasibility of Routine Intraoperative Cholangiography for Laparoscopic Cholecystectomy Kuei-Yen Tsai (Taiwan)
10:40-10:45
Instruction of Laparoscopic Cholecystectomy in Acute Cholecystitis Using Single-Incisional Laparoscopic Surgery Device Koji Asai (Japan)
10:45-10:50
Establishment of Optimal Treatment Process in Patient with Severe Acute Cholecystitis Youngju Ryu (Korea)
10:50-10:55
Validation of Tokyo Guideline 2018 Treatment Proposal for Acute Cholecystitis from a Single-Center Retrospective Analysis Tomoaki Bekki (Japan)
10:55-11:00
Multidisciplinary Management of Common Bile Duct Stones: A Single Centre Experience of 844 Patients over a Five and a Half Year Period Arul Jothi (India)
11:00-11:05
Accuracy of Magnetic Resonance Cholangiopancreatography for the Diagnosis of Choledocholithiasis in Clinical Practice Jie-gao Zhu (China)
11:05-11:10
Laparoscopic Surgery for Post Cholecystectomy Benign Biliary Stricture Amit Javed (India)
11:10-11:15
The Value of Lymphadenectomy in Surgical Resection of Perihilar Cholangiocarcinoma Tian Yang (China)
11:15-11:20
Prognostic Factors of Resectable Perihilar Cholangiocarcinoma Tian Yang (China)
Sep 6 (Fri) 10:30-11:30

[MO04] Mini Oral

Room 201, 2F
Chairperson(s)
Myoung Soo Kim (Korea), Hideki Ohdan (Japan)
10:30-10:35
Report of Donors of Living Donor Liver Transplantation at Dr. Cipto Mangunkusumo Hospital Jakarta: An Emerging Liver Transplant Center Arnetta N L Lalisang (Indonesia)
10:35-10:40
Parietal Peritoneum as an Autologous Substitute for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation Suk Kyun Hong (Korea)
10:40-10:45
Hepatitis B Vaccination and Entecavir Monotherapy Following Withdrawal of Hepatitis B Immunoglobulin (HBIG). An Alternative Approach to Prevention of Hepatitis B Reactivation After Liver Transplantation Johann Khan (Malaysia)
10:45-10:50
An Introduction of Everolimus in Subacute and Chronic Phases After Liver Transplantation - A Japanese Single Center Study Including ABO Incompatible Cases Kazuya Hirukawa (Japan)
10:50-10:55
Salvage Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis: A Case Report Onur Elvan Kirimker (Turkey)
10:55-11:00
Customized Reduction of Left Lobe/Left Lateral Graft in Pediatric LDLT Recipients: Outcomes of A Prospective Study Saurabh Singhal (India)
11:00-11:05
The Impact of Extra-Anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation on Biliary Complication, Graft and Patient Survival Jiyoun Hong (Korea)
11:05-11:10
A Novel Reconstruction Method for Adjacent Multiple Bile Duct During Living Donor Liver Transplantation; Dunking with Mucosal Eversion Technique Joodong Kim (Korea)
11:10-11:15
Production and Characterisation of Acellular Human Liver Matrix: Potential Auxiliary Liver Graft Abdul Hakeem (United Kingdom)
11:15-11:20
Outcomes After Robotic Donor Hepatectomy in 48 Consecutive Live Donors Seoung Yoon Rho (Korea)
Sep 6 (Fri) 10:30-11:30

[MO05] Mini Oral

Room 202, 2F
Chairperson(s)
Sung Su Yoon (Korea), Takao Ohtsuka (Japan)
10:30-10:35
CT-Perfusion in Diagnostic of Pancreatic Cancer Konstantin Sementsov (Russia)
10:35-10:40
Effectiveness of ERAS® (Enhanced Recovery After Surgery Program) Protocol Care Map in Pancreaticoduodenectomy Compared to Conventional Care: A Non-Randomized Controlled Trial Benya Taywaditep (Thailand)
10:40-10:45
Laparoscopic Partial Duodenectomy for the Non-Ampullary Tumors of the Duodenum Dianrong Xiu (China)
10:45-10:50
Impact of Enhanced Recovery After Surgery on Open and Laparoscopic Liver Surgery: A Single Center Cohort Study Alma Moekotte (United Kingdom)
10:50-10:55
Bacteriobilia Resistance to Antibiotic Prophylaxis Increases Morbidity After Pancreaticoduodenectomy Tommaso Stecca (Italy)
10:55-11:00
Organ Donation innovative Strategies for Southeast Asia: ODISSeA Jun Kit Koong (Malaysia)
11:00-11:05
Targeted Perioperative Fluid Therapy in Enhanced Recovery After Surgery in Pancreaticoduodenectomy Sharnice Koek (Australia)
11:05-11:10
Risk Factors and Outcomes of Postoperative Delirum After Major Hepatobiliary-Pancreatic Surgery; Single Center, Prospective Cohort Study Sang Wook Park (Korea)
11:10-11:15
Women in HPB Catherine Teh (Philippines)
11:15-11:20
Rediscovering Cadaver Based Teaching Nagesh Gowda (India)
Sep 6 (Fri) 10:30-12:30

[JS03] A-PHPBA&IHPBA Joint Symposium

Room 203, 2F
Great Gathering Around Gallbladder Cancer: Comprehensive Review and Our Future Directions 
Chairperson(s)
Jin-Young Jang (Korea), Palepu Jagannath (India)
10:30-10:50
Trends and Regional Differences of Epidemiology Xabier de Aretxabala (Chile)
10:50-11:10
Etiology and Genetic Mechanism William R. Jarnagin (USA)
11:10-11:30
Difficulty and Standardization of Pathologic Diagnosis Volkan Adsay (Turkey)
11:30-11:50
Current Evidence and Controversies in Surgical Treatment Seung Eun Lee (Korea)
11:50-12:10
Role of Chemotherapy and Radiotherapy Bhawna Sirohi (India)
12:10-12:30
Need and Proposal of International Collaboration Study Palepu Jagannath (India)
Sep 6 (Fri) 11:30-12:30

[SY15] Symposium

GBR 101-102, 1F
What's Making a Paradigm Shift in HCC? 
Chairperson(s)
Cornelis Dejong (Netherlands), Han Chu Lee (Korea)
11:30-11:50
Proteomics for Diagnostic and Prognostic Biomarkers in HCC Youngsoo Kim (Korea)
11:50-12:10
Immune Cell Profiling to Guide Treatment and Prediction of HCC Valerie Chew (Singapore)
12:10-12:30
Mutational Landscape and Structural Mutations in HCC Tatsuhiro Shibata (Japan)
Sep 6 (Fri) 11:30-11:50

[UP13] Update Lecture

GBR 103, 1F
Minimally Invasive Surgery for Pancreatic Cancer 
Chairperson(s)
Palanivelu Chinnusamy (India)
11:30-11:45
Current Status and Prospect of Minimally Invasive Surgery for Pancreatic Cancer Horacio J. Asbun (USA)
11:45-11:50
Discussion
Sep 6 (Fri) 11:50-12:10

[UP14] Update Lecture

GBR 103, 1F
Surgical Treatment for Acute Pancreatitis 
Chairperson(s)
Sujoy Pal (India)
11:50-12:05
Changing Role of Surgery in the Treatment of Acute Necrotizing Pancreatitis Saxon Connor (New Zealand)
12:05-12:10
Discussion
Sep 6 (Fri) 12:10-12:30

[UP15] Update Lecture

GBR 103, 1F
Update in Postoperative Pancreatic Fistula Definition 
Chairperson(s)
Seong Ho Choi (Korea)
12:10-12:25
Current ISGPF Definition of POPF Is Enough? Shailesh V. Shrikhande (India)
12:25-12:30
Discussion
Sep 6 (Fri) 11:30-12:30

[DE02] Debate Session

GBR 104-105, 1F
Gallbladder Polyps >1 cm: Is Cholecystectomy Necessary? 
Chairperson(s)
Sung-Sik Han (Korea), Sung Won Kwon (Korea)
11:30-11:50
Cholecystectomy Paleswan Joshi Lakhey (Nepal)
11:50-12:10
Observation Jong Kyun Lee (Korea)
12:10-12:30
Discussion
Sep 6 (Fri) 11:30-12:30

[UP16] Update Lecture

Room 201, 2F
Update in Immunology for Liver Transplantation 
Chairperson(s)
Koo Jeong Kang (Korea)
11:30-11:50
Adoptive Transfer of Immune Reaction in LT Hideki Ohdan (Japan)
11:50-12:10
Novel Immune Biomarkers in LT Gregory Mckenna (USA)
12:10-12:30
Operation Tolerance in LT Masaaki Watanabe (Japan)
Sep 6 (Fri) 11:30-12:30

[SY16] Symposium

Room 202, 2F
HBP Surgeon’s Burnout 
Chairperson(s)
Chul-Woon Chung (Korea), Tom Wilson (Australia)
11:30-11:45
The Problem of Burnout among HBP Surgeons Kenichi Hakamada (Japan)
11:45-12:00
Young Active Surgeon's View Dai Hoon Han (Korea)
12:00-12:15
Mentor Surgeon’s View Po-Da Chen (Taiwan)
12:15-12:30
Q&A
Sep 6 (Fri) 12:30-13:30

[LS03] Luncheon Symposium

GBR 101-102, 1F
Astellas Pharma Korea, Inc 
Chairperson(s)
Myoung Soo Kim (Korea), Hiroto Egawa (Japan)
12:30-13:10
Optimal Immunosuppression and dnDSA Development Nam-Joon Yi (Korea)
Sep 6 (Fri) 12:30-13:30

[LS04] Luncheon Symposium

GBR 103, 1F
Dong-A ST 
Chairperson(s)
Kyung-Suk Suh (Korea)
12:30-13:30
Virreal vs Viread Do Young Kim (Korea)
Sep 6 (Fri) 12:30-13:30

[LS05] Luncheon Symposium

GBR 104-105, 1F
InTheSmart Co., Ltd. 
Chairperson(s)
Kwang-Woong Lee (Korea)
12:30-13:30
Indocyanine Green Fluorescence Imaging in Liver Surgery Suk Kyun Hong (Korea)
Sep 6 (Fri) 13:30-15:00

[BO01] Best Oral

GBR 101-102, 1F
Chairperson(s)
Safi Dokmak (France), Tan To Cheung (Hong Kong)
13:30-13:40
Persistent Deleterious Effect of Ras and TP53 Co-Mutation After Resection of Colorectal Liver Metastasis Based on the Analysis of Conditional Recurrence Free Survival Estimates Yoshikuni Kawaguchi (United States)
13:40-13:50
Clinical Experience of the Single-Incision “Plus” Laparoscopic Hepatectomy: A Single-Center Study with 301 Cases Yesheng Chen (China)
13:50-14:00
Prospective Multicenter Study for Robotic Anatomical Major Liver Resection: Can Robotic Beginners Safely Perform ? Jae Hoon Lee (Korea)
14:00-14:10
Post Hepatectomy Liver Regeneration Stimulates Tumour Progression in the Residual Liver Georgina Riddiough (Australia)
14:10-14:20
Dynamic Changes of Circulating Tumor Cells Before and After Hepatectomy and Its Influence Factors in Patients with Hepatocellular Carcinoma shuilin dong (China)
14:20-14:30
Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Shin Hwang (Korea)
14:30-14:40
Model for Early Massive Recurrence (MEMR) After Curative-Intent Resection for Hepatocellular Carcinoma Hao-Chien Hung (Taiwan)
14:40-14:50
Validation of a Metroticket Approach to Prognosticate Overall Survival (OS) After Surgical Resection for Hepatocellular Carcinoma (HCC): A Multi-Center Study Aldwin Ong (Singapore)
14:50-15:00
Dendritic Cell Subsets and Serum Interleukin-12 in Schistosomal Hepatic Fibrosis: Relation to Severity of Liver Disease and Renal Injury Hayam El Aggan (Egypt)
Sep 6 (Fri) 13:30-15:00

[BO02] Best Oral

GBR 103, 1F
Chairperson(s)
Shailesh V. Shrikhande (India), Wenhui Lou (China)
13:30-13:40
Treatment Strategy of Pancreatic Neuroendocrine Tumors Suggested Based on Korean Multicenter Prognostic Factor Analysis Wooil Kwon (Korea)
13:40-13:50
Matching Treatment Strategies to Clinical Phenotype: Biomarker-Driven Selection for Neoadjuvant Therapy in Pancreatic Cancer Christopher Nahm (Australia)
13:50-14:00
Prognostic Factors for Predicting Early Recurrence Within the First Year of Surgery in Pancreatic Ductal Adenocarcinoma Naru Kim (Korea)
14:00-14:10
Chen’s Continuous Suture Technique for Invaginated Pancreaticojejunostomy Following Pancreaticoduodenectomy with No Grade B/C POPF and Zero Mortality in 644 Patients with Soft Pancreas and Small Pancreatic Duct Xiao-ping Chen (China)
14:10-14:20
Development of a Nomogram Based on Radiologic Findings for Predicting Malignancy and Invasiveness in Intraductal Papillary Mucinous Neoplasms of the Pancreas: An International, Multicenter Study Hyeong Seok Kim (Korea)
14:20-14:30
Modified Blumgart Mattress Suture Versus Conventional interrupted Suture in Pancreaticojejunostomy during Pancreaticoduodenectomy: Randomized Controlled Trial Seiko Hirono (Japan)
14:30-14:40
Pancreatic Cancer: Assessment of Neoadjuvant Chemotherapy Outcome Based on Radiomics of Pretreatment Computed Tomography Xiang Li (China)
14:40-14:50
Diffusion-Weighted MRI for Preoperative Prediction of Histologic Response in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Phase II Study (DIFFERENT Study) Ken-ichi Okada (Japan)
14:50-15:00
Prognostic Impact of Extranodal Extension in PDAC, Head Guisuk Park (Korea)
15:00-15:10
Minimally Invasive Versus Open Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Analysis from the U.S. Neuroendocrine Tumor Study Group Xu-Feng Zhang (China)
Sep 6 (Fri) 13:30-15:00

[BO03] Best Oral

GBR 104-105, 1F
Chairperson(s)
Masayuki Sho (Japan), Brian K. Goh (Singapore)
13:30-13:40
Prognostic Subclasses of Intrahepatic Cholangiocarcinoma by Integrative Molecular-Clinical Analysis and Potential Targeted Approach Keun Soo Ahn (Korea)
13:40-13:50
3D Laparoscopy Is Associated with a Better Surgical Outcomes in Choledocholithiasis Patients with Abdominal Adhesions Compared with 2D: A Propensity Score Analysis Xiaobo Bo (China)
13:50-14:00
Near-Infrared Cholangiography Can Facilitate a Laparoscopic Choledocholithotomy even After Upper Abdominal Surgery Shih Min Yin (Taiwan)
14:00-14:10
The Impact of Portal Vein Resection on Outcome of Hilar Cholangiocarcinoma Ki Beom Kim (Korea)
14:10-14:20
Indocyanine Green Navigated Early Laparoscopic Cholecystectomy in Post ERCP Patients for Choledochocystolithiasis Arul Jothi (India)
14:20-14:30
The Clinical Significance of Biliary Intraepithelial Neoplasia-3 in Proximal Resection Margin of Bile Duct in Perihilar Cholangiocarcinoma Dakyum Shin (Korea)
14:30-14:40
Does Indocyanine Green Cholangiography Identify Critical View of Safety Earlier in Laparoscopic Cholecystectomy ? Results from a Randomised Control Study in University Malaya Medical Centre Jun Kit Koong (Malaysia)
14:40-14:50
Early Outcomes of Robotic-Assisted Resection for Perihilar Cholangiocarcinoma Mikhail Efanov (Russia)
14:50-15:00
The Optimal Surgical Extent of T2 Gallbladder Cancer and the Effect of Location of the Tumor Wooil Kwon (Korea)
Sep 6 (Fri) 13:30-15:00

[BO04] Best Oral

Room 201, 2F
Chairperson(s)
Yan-Shen Shan (Taiwan), Jae-Won Joh (Korea)
13:30-13:40
Pure Laparoscopic Versus Open Donor Hepatectomy for Adult Living Donor Liver Transplantation - A Systematic Review and Meta-Analysis Abdul Hakeem (United Kingdom)
13:40-13:50
Current Strategy for ABO Incompatible Liver Transplantation in Kyoto University Shintaro Yagi (Japan)
13:50-14:00
The Real Impact of Downstaging on Survival Outcomes After Liver Transplantation for Hepatocellular Carcinoma Jae Hyun Kwon (Korea)
14:00-14:10
Zero Mortality Using Graft-to-Recipient Weight Ratio Less Than 0.6% in Adult Living Donor Liver Transplantation: Overcoming Small-for-Size Syndrome Tiffany CL Wong (Hong Kong)
14:10-14:20
Successful Triple Hepatic Venoplasty for Hepatic Vein Reconstruction in Pediatric Living Donor Liver Transplantation with Graft Size Mismatching Yu-Cheng Lin (Taiwan)
14:20-14:30
Sex-Determining Region on Y Chromosome Is a Key Mediator of Sexual Dimorphism in Hepatic Ischemia/Reperfusion Injury Xu-Feng Zhang (China)
14:30-14:40
Propensity-Score Matching Analysis of Postoperative Outcome Including Quality of Life After Single Incision Versus Multiport Laparoscopic Cholecystectomy: A Nationwide Prospective Multicenter Study in Korea Dae Joon Park (Korea)
14:40-14:50
IL-17A Promotes Liver Regeneration by Modulating IgM Producing B1a Cells in ALPPS Study Weiyi Zhang (Hong Kong)
14:50-15:00
The Effect of Enhanced Recovery After Surgery Program on Pancreaticoduodenectomy: A Randomized, Controlled Trial Dae Wook Hwang (Korea)
Sep 6 (Fri) 13:30-15:00

[YIA] Young Investigator Award

Room 202, 2F
Chairperson(s)
Kyung-Suk Suh (Korea), Toar J.M. Lalisang (Indonesia)
13:30-13:40
Long-Term Survival of 10,116 Korean Live Liver Donors Suk Kyun Hong (Korea)
13:40-13:50
Propensity Score Matching Study on Laparoscopic Versus Open Resection for Hepatocellular Carcinoma in Patients with Child-Pugh Class B Liver Cirrhosis: An International Multicenter Study Giammauro Berardi (Belgium)
13:50-14:00
Developing a Preoperative Serum Metabolome-Based Recurrence-Predicting Nomogram for Patients with Resected Pancreatic Ductal Adenocarcinoma Seoung Yoon Rho (Korea)
14:00-14:10
Efficacy of S-1 as Adjuvant Chemotherapy for Biliary Tract Carcinoma Yoichi Miyata (Japan)
14:10-14:20
Vascular Complications and Outcomes After Living Donor Liver Transplantation for Hilar Cholangiocarcinoma Ek Khoon Tan (United States)
14:20-14:30
Prognostic Significances of Numbers of Lymph Nodes Removed and Positive Nodes Ratio in Distal Bile Duct Cancer: A Multicenter Cohort Study Huisong Lee (Korea)
14:30-14:40
Comparing the Eighth Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Versus HKU Staging System for Postoperative Prognostic Evaluation in Hepatocellular Carcinoma Wong-Hoi She (Hong Kong)
14:40-14:50
Generation of S1P Is Upregulated and Is Associated with Lymphatic Metastasis in Human Biliary Tract Cancer Yuki Hirose (Japan)
14:50-15:00
Central Pancreatectomy Compared with Distal Pancreatectomy and Pancreaticoduodenectomy for Benign or Low-Grade Malignant Neoplasm in Terms of Postoperative Outcomes, Long-Term Pancreatic Endocrine, Exocrine Function and Parenchyma-Volume Changes: A Case-Controlled Study with Propensity Score Matching Dooho Lee (Korea)
Sep 6 (Fri) 13:30-15:00

[IV] Invited Video Lecture by Legendary Surgeons

Room 203, 2F
Chairperson(s)
Masakazu Yamamoto (Japan), Dong Wook Choi (Korea)
13:30-13:45
Combined Portal Vein, Right Hepatic Artery, Left Liver and Caudate Lobe Resection with Autovein Grafting for Hilar Cholangiocarcinoma Yuji Nimura (Japan)
13:45-14:00
Combined Arterial Resection for Locally Advanced Bilio-Pancreatic Malignancies Masaru Miyazaki (Japan)
14:00-14:15
Accumulated Surgical Skills on Laparoscopic Liver Surgery and Liver Transplantation Kazuyoshi Saito (Japan)
14:15-14:30
Portal Reconstruction Prior to Right Hepatectomy for Hilar Cholangiocarcinoma Hiroshi Shimada (Japan)
14:30-14:45
Left Trisectionectomy, PV & HA Resection and Reconstruction for Hilar CA Sung-Gyu Lee (Korea)
14:45-15:00
Q&A
Sep 6 (Fri) 15:20-16:20

[DE03] Debate Session

GBR 101-102, 1F
Management of HCC 
Chairperson(s)
Yonson Ku (Japan), Yang Won Nah (Korea)
HCC Staging and Treatment Algorithm: East Versus West 
15:20-15:30
Debate 1: Eastern Perspectives Tan To Cheung (Hong Kong)
15:30-15:40
Debate 2: Western Perspectives Vincent Lam (Australia)
15:40-15:50
Discussion
Surgical Resection for Locally Advanced HCC 
15:50-16:00
Debate 1: Try First! Norihiro Kokudo (Japan)
16:00-16:10
Debate 2: Re-Assess After Down-Staging Pierce Chow (Singapore)
16:10-16:20
Discussion
Sep 6 (Fri) 15:20-16:20

[DE04] Debate Session

GBR 103, 1F
Upfront Surgery vs. Neoadjuvant Treatment for Resectable Pancreatic Cancer 
Chairperson(s)
Sun-Whe Kim (Korea), Keiji Sano (Japan)
15:20-15:40
Neoadjuvant Treatment Hidenori Takahashi (Japan)
15:40-16:00
Upfront Surgery Sung-Sik Han (Korea)
16:00-16:20
Discussion
Sep 6 (Fri) 15:20-16:20

[DE05] Debate Session

GBR 104-105, 1F
Ampullectomy Versus Pancreaticoduodenectomy for Early Ampullary Cancer 
Chairperson(s)
Chol Kyoon Cho (Korea), Rajan Saxena (India)
15:20-15:40
Transduodenal Ampullectomy Kyeong Geun Lee (Korea)
15:40-16:00
Pancreaticoduodenectomy Yusuke Yamamoto (Japan)
16:00-16:20
Discussion
Sep 6 (Fri) 15:20-16:20

[DE06] Debate Session

Room 201, 2F
Post-Liver Transplantation Prophylaxis for Viral Hepatitis 
Chairperson(s)
Hiroto Egawa (Japan), Xiangcheng Li (China)
15:20-15:30
Debate 1 HBIG-Free Protocol James Fung (Hong Kong)
15:30-15:40
Debate 2 HBIG Is Still Cornerstone Jong Young Choi (Korea)
15:40-15:50
Discussion
15:50-16:00
Debate 1 Pre-Emtive or Prophylatic Sumihito Tamura (Japan)
16:00-16:10
Debate 2 With Histologic Evidence of Recurrence Koji Hashimoto (USA)
16:10-16:20
Discussion
Sep 6 (Fri) 15:20-16:20

[SY17] Symposium

Room 202, 2F
Training System of Robotic Surgery and Development of New Robotic Platform 
Chairperson(s)
Hyung Chul Kim (Korea), Bi-xiang Zhang (China)
15:20-15:40
Training Program of Robotic HBP Surgery Yi-Ming Shyr (Taiwan)
15:40-16:00
Development of Korean Robotic Surgery System (Revo-I) Woo-Jung Lee (Korea)
16:00-16:20
Application of Deep Learning in the Surgical Field KwangGi Kim (Korea)
Sep 6 (Fri) 16:20-17:50

[SY18] Symposium

GBR 101-102, 1F
Surgical Challenges in the Hepatectomy for HCC 
Chairperson(s)
Hong-Jin Kim (Korea), Shunichi Ariizumi (Japan)
16:20-16:40
Major Liver Resection with Vascular Reconstruction Deok-Bog Moon (Korea)
16:40-17:00
HCC with Bile Duct Thrombosis Anon Chotirosniramit (Thailand)
17:00-17:20
Advanced HCC with Portal Vein Thrombosis: Major Resection with Thrombectomy and Percutaneous Isolated Hepatic Perfusion (PIHP) Takumi Fukumoto (Japan)
17:20-17:40
Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients Masaki Kaibori (Japan)
17:40-17:50
Discussion
Sep 6 (Fri) 16:20-17:50

[SY19] Symposium

GBR 103, 1F
Surgical Strategy for IPMN 
Chairperson(s)
Ying Jui Chao (Taiwan), Krishnan Raman (Malaysia)
16:20-16:40
Adequate Extent of Resection for Invasive IPMN Chang Moo Kang (Korea)
16:40-17:00
Preoperative and Intraoperative Diagnostic Modalities Distingushing Malignant and Benign Lesions Thun Ingkakul (Thailand)
17:00-17:20
Treatment Option for Multifocal IPMN Brian K. Goh (Singapore)
17:20-17:50
Case Based Discussion Wooil Kwon (Korea)
Sep 6 (Fri) 16:20-17:50

[SY20] Symposium

GBR 104-105, 1F
Novel Surgical Techniques to Improve Curative Resection of Klatskin Tumor (Video) 
Chairperson(s)
Hee Chul Yu (Korea), Shoji Kubo (Japan), Sanjay Govil (India)
16:20-16:40
Vascular Resection During Curative Intent Resection for Hilar Cholangiocarcinoma Masato Nagino (Japan)
16:40-17:00
Preliminary Experience and Prognosis of Robotic Radical Resection for Hilar Cholangiocarcinoma Rong Liu (China)
17:00-17:20
Transhepatic Hilar Approach Shin Hwang (Korea)
17:20-17:40
3D Printing and Augmented Reality Navigation Surgery for Hilar Cholangiocarcinoma Jiahong Dong (China)
Sep 6 (Fri) 16:20-17:50

[SY21] Symposium

Room 201, 2F
Panel Discussion: Hepatic Venous Outflow Reconstruction in Living Donor Liver Transplantation 
Chairperson(s)
Jae-Won Joh (Korea), Susumu Eguchi (Japan)
Discussion 1: RHV Anastomosis 
16:20-16:25
Korean Center Jong Man Kim (Korea)
16:25-16:30
Japanese Center Toshimi Kaido (Japan)
16:30-16:35
Taiwanese Center Chih-Chi Wang (Taiwan)
16:35-16:40
Hong Kong Center Albert Chan (Hong Kong)
16:40-16:45
Turkish Center Deniz Balci (Turkey)
16:45-16:50
Indian Center Mohamed Rela (India)
16:50-17:05
Panel Discussion
Discussion 2: Multiple RIHVs 
17:05-17:10
Korean Center Dong Hwan Jung (Korea)
17:10-17:15
Japanese Center Toru Ikegami (Japan)
17:15-17:20
Taiwanese Center Rey-Heng Hu (Taiwan)
17:20-17:25
Hong Kong Center Kelvin K. C. NG (Hong Kong)
17:25-17:30
Turkish Center Deniz Balci (Turkey)
17:30-17:35
Indian Center Mohamed Rela (India)
17:35-17:50
Panel Discussion
Sep 6 (Fri) 16:20-17:50

[SY22] Symposium

Room 202, 2F
Robotic Surgery (Video Session) 
Chairperson(s)
In Seok Choi (Korea), Baiju Senadhipan (India)
16:20-16:40
Robotic Hepatectomy 1 Yao-Ming Wu (Taiwan)
16:40-17:00
Robotic Hepatectomy 2 Gi Hong Choi (Korea)
17:00-17:20
Robotic Pancreatectomy 1 Cheng-Ming Peng (Taiwan)
17:20-17:40
Robotic Pancreatectomy 2 Rong Liu (China)
Sep 7 (Sat) 07:30-08:20

[MO06] Mini Oral

GBR 101-102, 1F
Chairperson(s)
Nam-Joon Yi (Korea), Deniz Balci (Turkey)
07:30-07:35
Validation of Prognostic Impact of ADV Score for Resection of Hepatocellular Carcinoma: An Analysis Using Nationwide Korea Liver Cancer Registry Database Shin Hwang (Korea)
07:35-07:40
Association Between Postoperative Infectious Complications and Long-Term Prognosis After Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Study of 2,442 Patients Tian Yang (China)
07:40-07:45
A Novel Online Tool for Predicting Postoperative Liver Failure After Hepatectomy for Hepatocellular Carcinoma: A Multicentric Study from China Tian Yang (China)
07:45-07:50
Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Survival and Recurrence in Patients with Resectable Huge Hepatocelluar Carcinoma: A Multicentre Retrospective Analysis Tian Yang (China)
07:50-07:55
Immunomonitoring for Response and Adverse Events in Hepatocellular Carcinoma (HCC) Patients Treated with Immunotherapy Samuel Chuah (Singapore)
07:55-08:00
18F-FDG PET/CT as an Independent Predictor for Patients with Hepatocellular Carcinoma Combined with Major Portal Vein Tumor Thrombus Xu-Guang Hu (China)
08:00-08:05
Model to Predict Disease-Free Survival for Hepatocellular Carcinoma Patients with Surgical Resections Yin Lai (Taiwan)
08:05-08:10
Structure Guided Design and Development of High Affinity Selective Kinase Inhibitor: A Newer Therapeutic Approach to Attenuate Hepatocelular Carcinoma Imtaiyaz Hassan (India)
Sep 7 (Sat) 07:30-08:20

[MO07] Mini Oral

GBR 103, 1F
Chairperson(s)
Adrian Chiow (Singapore), Thun Ingkakul (Thailand)
07:30-07:35
Prognostic Value of Lymph Node Status and Lymphadenectomy in Pancreatic Neuroendocrine Tumors Junxi Xiang (China)
07:35-07:40
Comparing S.I.R.S. Score and Imrie Criteria in Predicting Organ Failure in Acute Pancreatitis Peng Soon Koh (Malaysia)
07:40-07:45
External Validation of a Nomogram to Predict Malignancy Risk in Patients with Intraductal Papillary Mucinous Neoplasms, Using Eastern and Western Cohorts Woohyun Jung (Korea)
07:45-07:50
Tumor Burden Score Predicting Tumor Recurrence of Non-Functional Pancreatic Neuroendocrine Tumors After Curative Resection Dinghui Dong (China)
07:50-07:55
Role of Surgical Resection in the Era of FOLFIRINOX for Advanced Pancreatic Cancer Yoonhyeong Byun (Korea)
07:55-08:00
Metformin Inhibited Pancreatic Cancer Growth by Upregulating miR-143/145 Cluster and Suppressing MAPK Signaling Pathway Zizhen Wu (China)
08:00-08:05
The Survival Impact of Surgical Waiting Time in Patients with Resectable Pancreatic Head Cancer Dae Wook Hwang (Korea)
08:05-08:10
The Yonsei Experience of 189 Laparoscopic Pancreaticoduodenectomies: A Propensity Score-Matched Analysis with Open Pancreaticoduodenectomy Munseok Choi (Korea)
Sep 7 (Sat) 07:30-08:20

[MO08] Mini Oral

GBR 104-105, 1F
Chairperson(s)
Ho Kyoung Hwang (Korea), Seung Ik Ahn (Korea)
07:30-07:35
Impact of Hemodilutional Autologous Blood Transfusion on Safety and Survival Outcomes Among Patients Undergoing Extensive Hepatobiliary Resection for Perihilar Cholangiocarcinoma Norihisa Kimura (Japan)
07:35-07:40
Common Bile Duct (CBD) Exploration for Patients with Unsuspecting Choledocholithiasis - A Ten-Year Study of Outcomes Rosemary Seagar (Australia)
07:40-07:45
Benefits and Pitfalls of Surgical Resection After Downstaging Concurrent Chemoradiation Therapy in Patients with Locally Advanced Perihilar Cholangiocarcinoma Incheon Kang (Korea)
07:45-07:50
Number of Positive Lymph Nodes and Lymphatic Invasion Are Significant Prognostic Factors for Distal Cholangiocarcinoma Shuji Suzuki (Japan)
07:50-07:55
Preoperative Assessment of Longitudinal Extension Margin of Cholangiocarcinoma with Per-Oral Video-Cholangioscopy Hiroshi Nakano (Japan)
07:55-08:00
Diagnostic Value of Serum Tumor Markers (Carcinoembryonic Antigen and Carbohydrate Antigen 19-9) in Gallbladder Cancer Su Young Hong (Korea)
08:00-08:05
Role of Flexible Choledochoscopy in Present Era – For Difficult Billiary Stones HARISCHANDRA MISHRA (India)
08:05-08:10
Types of Thalassemia Predict the Optimal Time of Surgery for Biliary Stone in Children Patchareeporn Tanming (Thailand)
Sep 7 (Sat) 07:30-08:20

[MO09] Mini Oral

Room 201, 2F
Chairperson(s)
Eduardo Fernandes (Brazil), Toru Ikegami (Japan)
07:30-07:35
Outcome of Living Donor Liver Transplantation for Secondary Biliary Cirrhosis in Adult: Single Center Experience Youngin Yoon (Korea)
07:35-07:40
Revisiting Donor Risk Over Two Decades of Single-Center Experience: More Attention on the Impact of Overweight Cheng-Maw Ho (Taiwan)
07:40-07:45
Effect of Everolimus on Hepatocellular Carcinoma Recurrence After Liver Transplantation Dong Jin Joo (Korea)
07:45-07:50
Platelet Count After Living Donor Liver Transplantation as a Surrogate for Portal Vein Pressure Monitoring and Predictor of Graft Hyperperfusion Syndrome: The “5-67-8” Rule Jeffrey Samuel Co (Taiwan)
07:50-07:55
Combined Shunt and Splenic Artery Ligation to Optimize Early Graft Function After Living Donor Liver Transplantation: Hitting One Bird with Two Stones Jeffrey Samuel Co (Taiwan)
07:55-08:00
Impact of the Baseline Anti-A/B IgG Titer on the Clinical Outcome in ABO-Incompatible Liver Transplantation Jae Geun Lee (Korea)
08:00-08:05
Outcomes in Patients of End Stage Liver Disease with Hepatorenal Syndrome Undergoing Living Donor Liver Transplant Srinivas Bojanapu (India)
08:05-08:10
Clinical Features and Prognosis of DIHBS (Diffuse Intrahepatic Biliary Stricture) After Adult ABO-Incompatible Living Donor Liver Transplantation Jae Hyun Kwon (Korea)
Sep 7 (Sat) 07:30-08:20

[MO10] Mini Oral

Room 202, 2F
Chairperson(s)
Junchul Chung (Korea), Sujoy Pal (India)
07:30-07:35
Development of a Radiomics Nomogram Based on the CE-CT Features to Predict the Survival of Upfront Resectable Patients with Pancreatic Head Cancer and Suspected Venous Invasion Tian-yu Tang (China)
07:35-07:40
Minimally-Invasive (Laparoscopic and Robot-Assisted) Versus Open Approach for Central Pancreatectomies - A Single-Center Experience Frederick Huynh (Korea)
07:40-07:45
Splenic Preservation Versus Splenectomy in Laparoscopic Distal Pancreatectomy: A Propensity Score Matched Study Alma Moekotte (United Kingdom)
07:45-07:50
Is the New T1 Category as Defined in the Eighth Edition Pancreatic Cancer Staging System an Improvement? Wooil Kwon (Korea)
07:50-07:55
Safe Zone for Left Renal Vein Exposure During Laparoscopic Radical Antegrade Modular Pancreatosplenectomy for Pancreatic Cancer Hitoe Nishino (Japan)
07:55-08:00
The Effect of Fibrinogen/Thrombin-Coated Collagen Patch (TachoSil®) Application in Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreatoduodenectomy: A Randomized Clinical Trial Jaewoo Kwon (Korea)
08:00-08:05
Minimally Invasive Pancreatic Necrosectomy: A Step-Up Approach Towards Ultra-Low Mortality in 103 Consecutive Procedures Abdul Hakeem (United Kingdom)
08:05-08:10
Alteration of Glucose Metabolism After Pancreatectomy Assessed with Biochemical Markers: A Korean Single Center Prospective Observational Study Jun Suh Lee (Korea)
Sep 7 (Sat) 07:30-12:00

[CM] A-PHPBA & ILLS Consensus Meeting

Room 203, 2F
Expert Consensus and Guidelines Conference on Minimally Invasive Donor Hepatectomy (MIDH) 
Organizer(s)
Kyung-Suk Suh (Korea), Daniel Cherqui (France)
07:30-07:35
Opening Remarks Kyung-Suk Suh (Korea)
07:35-07:40
Opening Remarks Daniel Cherqui (France)
07:40-07:50
Methodology and CQ*s *CQ = Clinical Question Ruben Ciria (Spain)
Rationale and Donor Outcomes 
Chairperson(s)
Chung-Mau Lo (Hong Kong), Kyung-Suk Suh (Korea)
07:50-08:10
CQ 1-3: Donor Advantage, Risk and Complications Daniel Cherqui (France)
08:10-08:30
CQ 4-6: Short Term Recovery and Long Term Quality of Life Benjamin Samstein (USA)
Recipient Outcomes 
Chairperson(s)
Chung-Mau Lo (Hong Kong), Kyung-Suk Suh (Korea)
08:30-08:50
CQ 7: Does MIDH Compromise Recipient Outcomes? Olivier Soubrane (France)
Techniques 
Chairperson(s)
Mohamed Rela (India), Daniel Cherqui (France)
08:50-09:10
CQ 8: Is Pure Laparoscopic Technique Applicable to All Types of Liver Grafts Kyung-Suk Suh (Korea)
09:10-09:30
CQ 9: Role of Hybrid and Hand Assisted Techniques Go Wakabayashi (Japan)
09:30-09:40
Refreshments
09:40-10:00
CQ 10: Anatomical Contraindications (Multiple Vessels or Bile Ducts…) Choon Hyuck David Kwon (USA)
10:00-10:20
CQ11: Role and Rationale of Robotics Dieter Broering (Saudi Arabia)
10:20-10:40
CQ 12-13: Best Transection Technique and Use of Pringle Maneuver Ki-Hun Kim (Korea)
10:40-11:00
CQ 14: Best Method for Bile Duct Identification and Closure Fernando Rotellar (Spain)
11:00-11:20
CQ 15: Best Method for Vascular Division (Clips, Stapler, Suture) Ho-Seong Han (Korea)
Training and Certification 
Chairperson(s)
Daniel Cherqui (France), Kyung-Suk Suh (Korea), Javier Briceno (Spain)
11:20-11:40
CQ 16-18: Who Should Do It, What Training, What Certification? Roberto I. Troisi (Saudi Arabia)
Closing Discussion 
Chairperson(s)
Mohamed Rela (India), Chung-Mau Lo (Hong Kong), Hiroto Egawa (Japan), Daniel Cherqui (France), Kyung-Suk Suh (Korea)
11:40-12:00
Closing Discussion
Sep 7 (Sat) 08:20-09:30

[SY23] Symposium

GBR 101-102, 1F
Evolvements in Intrahepatic Cholangiocarcinoma 
Chairperson(s)
Tin Tin Mar (Myanmar), Zhi-jun Zhu (China)
08:20-08:40
New Staging System: Changes from Previous Version Shin Hwang (Korea)
08:40-09:00
Combined Bile Duct Resection and LN Dissection: Routine or Selective or No Feng Shen (China)
09:00-09:20
Radiation Therapy for Intrahepatic Bile Duct Cancer Jin-Hong Park (Korea)
09:20-09:30
Discussion
Sep 7 (Sat) 08:20-09:30

[SY24] Symposium

GBR 103, 1F
New Treatment Modalities for Pancreatic Cancer 
Chairperson(s)
Yinmo Yang (China), Sang Geol Kim (Korea)
08:20-08:40
Current Progress in Systemic Thepary for Pancreatic Cancer Do-Youn Oh (Korea)
08:40-09:00
New Local Treatment for Locally Advanced Pancreatic Cancer Kai-Wen Huang (Taiwan)
09:00-09:20
Carbon-Ion Radiotherapy for Pancreatic Cancer Makoto Shinoto (Japan)
09:20-09:30
Discussion
Sep 7 (Sat) 08:20-09:30

[SY25] Symposium

GBR 104-105, 1F
Enhanced Recovery After Laparoscopic Cholecystectomy 
Chairperson(s)
Hyeon Kook Lee (Korea), Shridhar Ganpathi Iyer (Singapore)
08:20-08:40
Simple Maneuver to Reduce Pain After Laparoscopic Cholecystectomy; How Can Surgeons Do Better? Shridhar Ganpathi Iyer (Singapore)
08:40-09:00
Strategy to Reduce Preoperative NPO Time and Postoperative PONV, Pain in Laparoscopic Cholecystectomy: the Role of Anesthesiologist Jeong Soo Lee (Korea)
09:00-09:20
Day Care vs Overnight Stay After Laparoscopic Cholecystectomy; Personal Experience and Limitation in Practice Aswini Kumar Pujahari (India)
Sep 7 (Sat) 08:20-09:30

[SY26] Symposium

Room 201, 2F
Upcoming Issues in Liver Transplantation for Alcoholic Liver Disease (ALD) and Non-Alcoholic Steatohepatitis (NASH) 
Chairperson(s)
Kwang-Hyub Han (Korea), Krishnakumar Madhavan (Singapore)
08:20-08:35
Optimal Psychosocial and Biological Surveillance in LT for ALD Hiroto Egawa (Japan)
08:35-08:50
Currnet Situation and Unresolved Issues in LT for ALD Geoff McCaughan (Australia)
08:50-09:05
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease Guidelines Won Kim (Korea)
09:05-09:20
The Prevalence and Consequences of Recurrent or De-Novo NAFLD After LT Yock Young Dan (Singapore)
09:20-09:30
Discussion
Sep 7 (Sat) 08:20-09:30

[SY27] Symposium

Room 202, 2F
Various Infectious Conditions in the Fields of HBP 
Chairperson(s)
Bong-Wan Kim (Korea), Razman Jarmin (Malaysia)
08:20-08:35
Hydatid Cyst and Its Treatment Jonathan Koea (New Zealand)
08:35-08:50
Updates on Infectious Liver Abscess Razman Jarmin (Malaysia)
08:50-09:05
Opisthorchis Infection Prawat Kositamongkol (Thailand)
09:05-09:20
Pancreatitis and Infection Shuji Isaji (Japan)
Sep 7 (Sat) 09:30-09:50

[UP17] Update Lecture

GBR 101-102, 1F
Recent Updates in Benign Liver Diseases 
Chairperson(s)
Hee Chul Yu (Korea)
09:30-09:50
Genetic Profiling & Molecular Classification of Hepatic Adenoma: Its Clinical Significance Safi Dokmak (France)
Sep 7 (Sat) 09:30-09:50

[UP18] Update Lecture

GBR 103, 1F
Biomedical Perspectives and Application in Pancreatic Ductal Adenocarcinoma 
Chairperson(s)
Sang-Jae Park (Korea)
09:30-09:45
Genomic and Molecular Characterization of Pancreatic Cancer Daehee Hwang (Korea)
09:45-09:50
Discussion
Sep 7 (Sat) 09:30-09:50

[UP19] Update Lecture

GBR 104-105, 1F
What Is New in Intraductal Papillary Neoplasm of the Bile Duct? 
Chairperson(s)
Keiichi Kubota (Japan), Yong-Jie Zhang (China)
09:30-09:45
Pathological Overview of IPNB for Surgeons Kee-Taek Jang (Korea)
09:45-09:50
Discussion
Sep 7 (Sat) 09:30-09:50

[UP20] Update Lecture

Room 201, 2F
Bioengineering Techniques and Liver Transplantation 
Chairperson(s)
Dong Ho Choi (Korea)
09:30-09:50
Hepatocyte Transplantation and Cell Therapy for Liver Diseases Timothy Pruett (USA)
Sep 7 (Sat) 09:30-09:50

[UP21] Update Lecture

Room 202, 2F
Knowledge Is Power : Educating Surgeons 
Chairperson(s)
Joon Seong Park (Korea), Sudeep Shah (India)
09:30-09:45
Immune Therapy : Bench to Clinical Approach Eui-Cheol Shin (Korea)
09:45-09:50
Discussion
Sep 7 (Sat) 09:50-10:50

[MO11] Mini Oral

GBR 101-102, 1F
Chairperson(s)
Yoonjin Hwang (Korea), Tian Yang (China)
09:50-09:55
Adjuvant Therapy Using Ex Vivo-Expanded Allogenic Natural Killer Cells in Hepatectomy Patients with Hepatitis B Virus Related Solitary Hepatocellular Carcinoma: MG4101 study Jong Man Kim (Korea)
09:55-10:00
Liver Resection for Hepatocellular Carcinoma with Two Tumor Nodules: A Multicenter Cohort Study Tian Yang (China)
10:00-10:05
Anatomical Resection Versus Non-Anatomical Resection on Single Hepatocellular Carcinoma (HCC): A Retrospective Study of 1515 Cases Chao Wang (China)
10:05-10:10
Novel SNPs for Screening of Nonalcoholic Fatty Liver Disease: A Korean Population-Based Study Min-Su Park (Korea)
10:10-10:15
Surgical Technique and Short-Term Outcomes of Laparoscopic Repeat Hepatectomy Takahiro Yoshikawa (Japan)
10:15-10:20
The Potential Applications of Metabolomics for Hepatocellular Carcinoma After Partial Hepatectomies Ming-Chin Yu (Taiwan)
10:20-10:25
Improved Outcomes of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver Yujin Kwon (Korea)
10:25-10:30
Conditional Overall and Disease-Free Survival After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Study Liangshuo Hu (China)
10:30-10:35
Preliminary Result of PLEX (Plasma Exchange) in Acute and Acute on Chronic Liver Failure Chandrasekar Murugesan (India)
10:35-10:40
Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma: Friend or Foe? A Meta Analysis Wen Chen (China)
Sep 7 (Sat) 09:50-10:50

[MO12] Mini Oral

GBR 103, 1F
Chairperson(s)
Kai-Wen Huang (Taiwan), Dae Wook Hwang (Korea)
09:50-09:55
Clinical Outcomes of the Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine vs. FOLFIRINOX Yoo Jin Choi (Korea)
09:55-10:00
Long-Term Outcome of Conversion Surgery for Initially Unresectable Pancreatic Cancer: A Single Institutional Experience Keita Wada (Japan)
10:00-10:05
Two Stage Whipple Operation for High Grade Pancreas Trauma- A Single Center Experience Yi Ping Sng (Taiwan)
10:05-10:10
Neoadjuvant Chemoradiotherapy Significantly Improves the Prognosis in Resectable and Borderline Resectable Pancreatic Cancer with Venous involvement Kenji Nakagawa (Japan)
10:10-10:15
Comparative Study of Alternative Fistula Risk Score (A-FRS) and Fistula Risk Score (FRS) for Predicting the Risk of Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Vikram Chaudhari (India)
10:15-10:20
Laparoscopic Pancreaticoduodenectomy: CUSUM Analysis in a Developing Single Surgeon Jung Woo Lee (Korea)
10:20-10:25
Synthetic Lethality in non-BRCA Mutant PDAC with Codelivery JQ1 and Olaparib via a Plectin1 Targeting Peptide Nanoparticle Yazhou Wang (China)
10:25-10:30
Does Radicality of Frey Procedure for Chronic Pancreatitis Influence the Late Re-Intervention Rate After Surgery? Hariharan Ramesh (India)
10:30-10:35
Fistula Risk Score-Adjusted Comparison of Postoperative Pancreatic Fistula Between Laparoscopic Versus Open Pancreatoduodenectomy Boram Lee (Korea)
10:35-10:40
Venous Reconstruction with the Parietal Peritoneum. The Long Results in 106 Patients Safi Dokmak (France)
Sep 7 (Sat) 09:50-10:50

[MO13] Mini Oral

GBR 104-105, 1F
Chairperson(s)
Sang Mok Lee (Korea), Palanisamy Senthilnathan (India)
09:50-09:55
A Study of Metachronous Biliary Recurrence of Intraductal Papillary Neoplasm of the Bile Duct (IPNB) After Surgical Resection Eri Nakadai (Japan)
09:55-10:00
Survival After Perihilar Cholangiocarcinoma Resection —Development of a Prognostic Nomogram and Comparison of Three Prognostic Schemes Hao Feng (China)
10:00-10:05
Regional or Extended Lymphadenectomy Trial (RELAY-Trial) in Hilar Cholangiocarcinoma Resection—A Prospective, Multicenter, Randomized Controlled Trial Hao Feng (China)
10:05-10:10
The Oncologic Outcomes of the Preoperative Biliary Drainage in the Ampulla of Vater Cancer Yoonhyeong Byun (Korea)
10:10-10:15
Laparoscopic Hepatectomy Combined with Choledochoscopy in the Treatment of Intrahepatic and Common Bile Duct Stones Ying Peng (China)
10:15-10:20
Surgical Resection for T1b Gallbladder Cancer: Is Radical Resection Necessary? Kizuki Yuza (Japan)
10:20-10:25
Can Cystic Lymph Node Be Considered a Sentinel Lymph Node for Gallbladder Cancer? Jae Yool Jang (Korea)
10:25-10:30
Relevance of the Tumor Site in Node Metastasis for Intrahepatic Cholangiocarcinoma Jae Yool Jang (Korea)
10:30-10:35
Major Hepatectomy with Hepatic Artery Resection and Microscopic Reconstruction for Advanced Biliary Tract Cancer Shinya Hayami (Japan)
10:35-10:40
Role of PET/CT in Operable Hilar Cholangiocarcinoma Wong-Hoi She (Hong Kong)
Sep 7 (Sat) 09:50-10:50

[MO14] Mini Oral

Room 201, 2F
Chairperson(s)
Shin Hwang (Korea), Kiyoshi Hasegawa (Japan)
09:50-09:55
Tumor Marker-Based Risk Assessment of Hepatocellular Carcinoma Recurrence After Liver Transplantation Yong-Kyu Chung (Korea)
09:55-10:00
The Importance of Post-Transplantation Platelet Count and Its Correlation with Liver Graft Hemodynamics After Living Donor Liver Transplantation Ling Wang (Taiwan)
10:00-10:05
Association of Posttransplant Donor-Specific HLA Antibody with Liver Fibrosis After Pediatric Liver Transplantation Kazuaki Tokodai (Japan)
10:05-10:10
Characteristics and Risk Factors of Fatty Liver Disease Development and Nonalcoholic Steatohepatitis Recurrence After Liver Transplantation Kazuaki Tokodai (Japan)
10:10-10:15
Clinical Outcomes of Laparoscopic Living Donor Right Hepatectomy Without Pringle’s and Hanging Maneuver Young Seok Han (Korea)
10:15-10:20
Technical Considerations in Liver Transplantation for Biliary Atresia with Situs Inversus: A Single Center Experience and a Literature Review Masahiro Takeda (Japan)
10:20-10:25
Are Only Pre-Transplant Rituximab and Plasma Exchange Sufficient for Desensitization Protocol of ABO Incompatible LDLT? Ja Ryung Han (Korea)
10:25-10:30
Is Left Lobe LDLT Adequate for Patients with a Unsuitable Right Lobe Donor Bhargava Chikkala (India)
10:30-10:35
Validating a New Software for 3D Reconstruction and Volumetric Analysis in Living Donor Liver Transplantation Onur Elvan Kirimker (Turkey)
10:35-10:40
Neutrophil-to-Lymphocyte Ratio Predicts Acute Cellular Rejection in Living Donor Liver Transplantation Boram Lee (Korea)
Sep 7 (Sat) 09:50-10:50

[MO15] Mini Oral

Room 202, 2F
Chairperson(s)
Dong-Shik Lee (Korea), Sa-ard Treepongkaruna (Thailand)
09:50-09:55
Multidisciplinary Treatments for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus Satoshi Katagiri (Japan)
09:55-10:00
Laparoscopic Versus Open Complex Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Study Wanguang Zhang (China)
10:00-10:05
Clinical Scoring Model Determines Surgical Modality for Solitary and Small Hepatocellular Carcinoma with Child-Pugh A Liver Function Erlei Zhang (China)
10:05-10:10
Robotic Major Liver Resections: Surgical Outcomes Compared with Open Major Liver Resections Hye Yeon Yang (Korea)
10:10-10:15
Adjuvant TACE Improves Disease-Free Survival in HCC with No Vascular Invasion After Hepatectomy – Result of Randomized Controlled Trial Yue Sun Cheung (Hong Kong)
10:15-10:20
Risk Factors for Pulmonary Complications After Hepatic Resection : A Retrospective Observational Study Jin Kyu Cho (Korea)
10:20-10:25
Curative Treatment for Intermediate Stage Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Staging Classification Chakrit Paibulparadorn (Thailand)
10:25-10:30
The Benefits of Curative R0 Surgical Resection with a Selective Bile Duct Preserving Approach for Hepatocellular Carcinoma with Macroscopic Bile Duct Tumor Thrombus: A Single Center Retrospective Comparative Study Worakitti Lapisatepun (Thailand)
10:30-10:35
Clinical Outcome of Liver Resection for Metachronous Colorectal Liver Metastasis Taku Iida (Japan)
10:35-10:40
Simultaneous Laparoscopic Hepatectomy and Colectomy for Colorectal Liver Metastases: Current State and Considerations Christina Delimpalta (United Kingdom)
Sep 7 (Sat) 11:20-12:20

[PL] Plenary Oral

GBR 103, 1F
Chairperson(s)
Toar J.M. Lalisang (Indonesia), Hee Chul Yu (Korea)
11:20-11:30
An Intention-to-Treat Competing-Risk Model for Candidates with Hepatocellular Cancer Awaiting Liver Transplantation Quirino Lai (Belgium)
11:30-11:40
Different Surgical Strategies of T2 Gallbladder Cancer According to Tumor Location?: A Korea Tumor Registry System-BiliaryPancreas (KOTUS-BP) Database Analysis Seung Eun Lee (Korea)
11:40-11:50
Changing Trends and Outcome Associated with the Adoption of Minimally-Invasive Hepatectomies: Experience with 500 Consecutive Cases at Singapore General Hospital Brian K. Goh (Singapore)
11:50-12:00
Development of a Prediction Model for Survival in Patients with Resected Ampullary Adenocarcinoma: An International Multicenter Study Alma Moekotte (United Kingdom)
12:00-12:10
Multicenter Propensity Score Based Analysis of Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma in Elderly Patients Takeo Nomi (Japan)
12:10-12:20
Stapler Cartridge Selection According to the Pancreatic Characteristics in Distal Pancreatectomy Hongbeom Kim (Korea)
Sep 7 (Sat) 12:20-12:50

[CL] Closing & Awards Ceremony

GBR 103, 1F